BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology 2014;60:2099-108. [PMID: 25164003 DOI: 10.1002/hep.27406] [Cited by in Crossref: 685] [Cited by in F6Publishing: 645] [Article Influence: 85.6] [Reference Citation Analysis]
Number Citing Articles
1 Gijbels E, Pieters A, De Muynck K, Vinken M, Devisscher L. Rodent models of cholestatic liver disease: A practical guide for translational research. Liver Int 2021;41:656-82. [PMID: 33486884 DOI: 10.1111/liv.14800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wu C, Lin J, Weng Y, Zeng DN, Xu J, Luo S, Xu L, Liu M, Hua Q, Liu CQ, Li JQ, Liao J, Sun C, Zhou J, Chen MS, Liu C, Guo Z, Zhuang SM, Huang JH, Zheng L. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. J Clin Invest 2020;130:4679-93. [PMID: 32497024 DOI: 10.1172/JCI135048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
3 Tian YL, Ji JJ, Chen LN, Cui XL, Liu ST, Mao L, Qiu YD, Li BB. Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy. World J Clin Cases 2020; 8(4): 713-722 [PMID: 32149055 DOI: 10.12998/wjcc.v8.i4.713] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin D, Jiang X, Zhao Y, Zhai X, Yang X. Komagataeibacter hansenii CGMCC 3917 alleviates alcohol-induced liver injury by regulating fatty acid metabolism and intestinal microbiota diversity in mice. Food Funct 2020;11:4591-604. [PMID: 32432239 DOI: 10.1039/c9fo02040c] [Reference Citation Analysis]
5 Akbar SM, Al-mahtab M, Khan SI, Shrestha A, Tabassum S, Hiasa Y. Current trends in hepatitis B vaccination. Future Virology 2016;11:369-78. [DOI: 10.2217/fvl-2016-0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Low J, Carroll C, Wilson J, Craig R, Vadera S, Cococcia S, Thorburn D, Stone P, Marshall A, Vickerstaff V. Do screening tools assess palliative care needs and 12-month mortality in patients admitted to hepatology in-patient wards? Frontline Gastroenterol. [DOI: 10.1136/flgastro-2020-101709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu W, Wang J, Huang Q, Lu Q, Liang W. Comparison of MRI Features of Epithelioid Hepatic Angiomyolipoma and Hepatocellular Carcinoma: Imaging Data From Two Centers. Front Oncol. 2018;8:600. [PMID: 30619742 DOI: 10.3389/fonc.2018.00600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gao Y, Shi W, Yao H, Ai Y, Li R, Wang Z, Liu T, Dai W, Xiao X, Zhao J, Niu M, Bai Z. An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism. Front Pharmacol 2021;12:747010. [PMID: 34630116 DOI: 10.3389/fphar.2021.747010] [Reference Citation Analysis]
9 Mu D, Yuan FC, Chen Y, Jiang XY, Yan L, Jiang LY, Gong JP, Zhang DZ, Ren H, Liao Y. Baseline value of intrahepatic HBV DNA over cccDNA predicts patient's response to interferon therapy. Sci Rep. 2017;7:5937. [PMID: 28725013 DOI: 10.1038/s41598-017-05242-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
10 Bi Y, Li J, Yang Y, Wang Q, Wang Q, Zhang X, Dong G, Wang Y, Duan Z, Shu Z, Liu T, Chen Y, Zhang K, Hong F. Human liver stem cells attenuate concanavalin A-induced acute liver injury by modulating myeloid-derived suppressor cells and CD4+ T cells in mice. Stem Cell Res Ther 2019;10:22. [PMID: 30635035 DOI: 10.1186/s13287-018-1128-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH. Therapeutic cancer vaccines. J Clin Invest. 2015;125:3401-3412. [PMID: 26214521 DOI: 10.1172/jci80009] [Cited by in Crossref: 318] [Cited by in F6Publishing: 177] [Article Influence: 45.4] [Reference Citation Analysis]
12 Zhang W, Qi S, Zhuo J, Wen S, Fang C. Concordance Study in Hepatectomy Recommendations Between Watson for Oncology and Clinical Practice for Patients with Hepatocellular Carcinoma in China. World J Surg 2020;44:1945-53. [PMID: 32020325 DOI: 10.1007/s00268-020-05401-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ou G, Liu X, Yang L, Yu H, Ji X, Liu F, Xu H, Qian L, Wang J, Liu Z. Relationship between HLA-DPA1 mRNA expression and susceptibility to hepatitis B. J Viral Hepat 2019;26:155-61. [PMID: 30267609 DOI: 10.1111/jvh.13012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Pang Y, Lv J, Kartsonaki C, Yu C, Guo Y, Chen Y, Yang L, Millwood IY, Walters RG, Wang S, Chen J, Chen Z, Li L. Metabolic risk factors, genetic predisposition, and risk of severe liver disease in Chinese: a prospective study of 0.5 million people. Am J Clin Nutr 2021;114:496-504. [PMID: 33964851 DOI: 10.1093/ajcn/nqab099] [Reference Citation Analysis]
15 Zhao R, Wu W, Zhou Z, Zheng X, Sun W, Shi Y, Yu H, Wang F, Zhao H, Sun S, Jin L, Sheng J, Shi Y. Prognostic utility of novel biomarkers in acute-on-chronic liver failure (ACLF) associated with hepatitis B: A multicenter prospective study. Hepatol Res 2019;49:42-50. [PMID: 30246902 DOI: 10.1111/hepr.13251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Dai J, Zhao J, Du Y, Zhuang L, McNeil EB, Chongsuvivatwong V. Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China. Cancer Manag Res 2020;12:6209-20. [PMID: 32884337 DOI: 10.2147/CMAR.S259195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Song X, Yin S, Zhang E, Fan L, Ye M, Zhang Y, Hu H. Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase. Oncotarget 2016;7:65732-43. [PMID: 27582549 DOI: 10.18632/oncotarget.11610] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
18 Zhu Z, Qin Y, Liang Q, Xia W, Zhang T, Wang W, Zhang M, Jiang T, Wu H, Tian Y. Increased HBV Coinfection and Decreased IFN-γ-Producing HBV-Specific CD8+ T Cell Numbers During HIV Disease Progression. Front Immunol 2022;13:861804. [PMID: 35432386 DOI: 10.3389/fimmu.2022.861804] [Reference Citation Analysis]
19 Wu SY, Wang WJ, Dou JH, Gong LK. Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury. Acta Pharmacol Sin 2021;42:18-26. [PMID: 32144337 DOI: 10.1038/s41401-020-0383-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
20 Wu C, Wu P, Li P, Cheng F, Du Y, He S, Lang H. Construction of an index system of core competence assessment for infectious disease specialist nurse in China: a Delphi study. BMC Infect Dis 2021;21:791. [PMID: 34376141 DOI: 10.1186/s12879-021-06402-2] [Reference Citation Analysis]
21 Ren SS, Xu LL, Wang P, Li L, Hu YT, Xu MQ, Zhang M, Yan LN, Wen TF, Li B, Wang WT, Yang JY. Circadian Rhythms Have Effects on Surgical Outcomes of Liver Transplantation for Patients With Hepatocellular Carcinoma: A Retrospective Analysis of 147 Cases in a Single Center. Transplant Proc 2019;51:1913-9. [PMID: 31399175 DOI: 10.1016/j.transproceed.2019.03.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Wang YC, Yang SS, Su CW, Wang YJ, Lee KC, Huo TI, Lin HC, Huang YH. Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis. Sci Rep. 2016;6:29605. [PMID: 27405043 DOI: 10.1038/srep29605] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
23 Tang X, Liu B, Zhang C, Tang W, Liang S, Xiao Y, Deng R, Li Z. SENP2 Reduces Hepatocellular Carcinoma Stemness and Improves Sorafenib Sensitivity Through Inactivating the AKT/GSK3β/CTNNB1 Pathway. Front Oncol 2021;11:773045. [PMID: 34950583 DOI: 10.3389/fonc.2021.773045] [Reference Citation Analysis]
24 Huang R, Rao H, Lv F, Nan Y, Ren W, Huang Y, Li J, Tang H, Huang Y, Chalasani N, Wei L. Attitudes of Chinese Patients with Non-alcoholic Fatty Liver Disease Toward Participation in Clinical Trials from a National Multicenter Survey. Ther Innov Regul Sci 2022. [PMID: 35171499 DOI: 10.1007/s43441-022-00380-6] [Reference Citation Analysis]
25 Wu X, Zhang F, Yu M, Wang H. Review of the Chinese Landscape in Phase I Clinical Trials for Noncancer Innovative Drugs Over 2015 to 2020. Clin Pharmacol Drug Dev 2022. [PMID: 35711154 DOI: 10.1002/cpdd.1131] [Reference Citation Analysis]
26 Yang W, Wang Y, Zhang P, Wang T, Li C, Tong X, Zeng X, Yin Y, Tao K, Li R, Kolaczkowska E. Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/5766434] [Reference Citation Analysis]
27 Wei L, Ye Z, Bao Z, Xu X, Lin X, Chen L. Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading. Clinics (Sao Paulo) 2020;75:e1670. [PMID: 32935822 DOI: 10.6061/clinics/2020/e1670] [Reference Citation Analysis]
28 Luo W, Wu S, Chen H, Wu Y, Peng J. Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon. J Int Med Res 2021;49:3000605211025139. [PMID: 34182813 DOI: 10.1177/03000605211025139] [Reference Citation Analysis]
29 Peng S, Chen H, Li X, Du Y, Gan Y. Maternal age and educational level modify the association between chronic hepatitis B infection and preterm labor. BMC Pregnancy Childbirth 2020;20:38. [PMID: 31937269 DOI: 10.1186/s12884-020-2729-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Zhang X, Gao Q, Zhuang Q, Zhang L, Wang S, Du L, Yuan W, Wang C, Tian Q, Yu H, Zhao Y, Liu Y. A dual-functional nanovehicle with fluorescent tracking and its targeted killing effects on hepatocellular carcinoma cells. RSC Adv 2021;11:10986-95. [PMID: 35423573 DOI: 10.1039/d0ra10486h] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Wang J, Liao AM, Thakur K, Zhang JG, Huang JH, Wei ZJ. Licochalcone B Extracted from Glycyrrhiza uralensis Fisch Induces Apoptotic Effects in Human Hepatoma Cell HepG2. J Agric Food Chem 2019;67:3341-53. [PMID: 30835110 DOI: 10.1021/acs.jafc.9b00324] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
32 Shen J, He L, Li C, Wen T, Chen W, Lu C, Yan L, Li B, Yang J. Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy. Gut Liver 2017;11:684-92. [PMID: 28651303 DOI: 10.5009/gnl16465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wang C, Liu S, Lu L, Liao S, Yue H, Dong Q, Xin Y, Xuan S. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.66149] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Yu J, Xing L, Tan X. The new treatment mode research of hepatitis B based on ant colony algorithm. J Comb Optim 2021;42:740-59. [DOI: 10.1007/s10878-019-00478-y] [Reference Citation Analysis]
35 Wen Y, Cai X, Chen S, Fu W, Chai D, Zhang H, Zhang Y. 7-Methoxy-1-Tetralone Induces Apoptosis, Suppresses Cell Proliferation and Migration in Hepatocellular Carcinoma via Regulating c-Met, p-AKT, NF-κB, MMP2, and MMP9 Expression. Front Oncol 2020;10:58. [PMID: 32117722 DOI: 10.3389/fonc.2020.00058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Chen T, Lin YX, Zha Y, Sun Y, Tian J, Yang Z, Lin SW, Yu F, Chen ZS, Kuang BH, Lei JJ, Nie YJ, Xu Y, Tian DB, Li YZ, Yang B, Xu Q, Yang L, Zhong N, Zheng M, Li Y, Zhao J, Zhang XY, Feng L. A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19. mBio 2021;12:e0137221. [PMID: 34634929 DOI: 10.1128/mBio.01372-21] [Reference Citation Analysis]
37 Yang Y, Min Z. Effect of long non‑coding RNA AK021443 on promoting hepatic fibrosis in vitro. Mol Med Rep 2021;23:196. [PMID: 33495828 DOI: 10.3892/mmr.2021.11835] [Reference Citation Analysis]
38 Feng Y, Wang AT, Jia HH, Zhao M, Yu H. A Brief Analysis of Mesenchymal Stem Cells as Biological Drugs for the Treatment of Acute-on-Chronic Liver Failure (ACLF): Safety and Potency. Curr Stem Cell Res Ther 2020;15:202-10. [PMID: 31893994 DOI: 10.2174/1574888X15666200101124317] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wang Y, Shi JF, Wang L, Yan Y, Yao H, Dai M, Chen T, Qu C. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China. Int J Infect Dis 2019;78:130-9. [PMID: 30466898 DOI: 10.1016/j.ijid.2018.08.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Lu Y, Wang G, Li C. Expression of peripheral monocytic programmed death ligand-1 in severe sepsis combined with HBV-related cirrhosis. A pilot observational study. Cent Eur J Immunol 2021;46:217-24. [PMID: 34764790 DOI: 10.5114/ceji.2021.108179] [Reference Citation Analysis]
41 Jie Y, Liu G, E M, Li Y, Xu G, Guo J, Li Y, Rong G, Li Y, Gu A. Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma. Eur J Pharmacol 2021;906:174214. [PMID: 34116044 DOI: 10.1016/j.ejphar.2021.174214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zhuge S, Ge C, Yang Y, Cui Y, Yue X, Zhang Z, Xu H, Huang A, Zhao Y. The prevalence of occult HBV infection in immunized children with HBsAg-positive parents: a hospital-based analysis. Hepatol Int 2020;14:503-12. [PMID: 32472310 DOI: 10.1007/s12072-020-10055-9] [Reference Citation Analysis]
43 Cheng C, Deng X, Xu K. Increased expression of sterol regulatory element binding protein‑2 alleviates autophagic dysfunction in NAFLD. Int J Mol Med 2018;41:1877-86. [PMID: 29336468 DOI: 10.3892/ijmm.2018.3389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
44 Megahed FAK, Zhou X, Sun P. The Interactions between HBV and the Innate Immunity of Hepatocytes. Viruses 2020;12:E285. [PMID: 32151000 DOI: 10.3390/v12030285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
45 Du S, Yang JZ, Chen J, Zhou WG, Sun YY. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching. PLoS One 2020;15:e0227242. [PMID: 31918433 DOI: 10.1371/journal.pone.0227242] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
46 Im PK, Millwood IY, Kartsonaki C, Guo Y, Chen Y, Turnbull I, Yu C, Du H, Pei P, Lv J, Walters RG, Li L, Yang L, Chen Z; China Kadoorie Biobank (CKB) collaborative group. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults. BMC Med 2021;19:216. [PMID: 34530818 DOI: 10.1186/s12916-021-02079-1] [Reference Citation Analysis]
47 Low JTS, Rohde G, Pittordou K, Candy B, Davis S, Marshall A, Stone P. Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals. J Hepatol 2018;69:1260-73. [PMID: 30243996 DOI: 10.1016/j.jhep.2018.08.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
48 Zhang S, Chen C, Peng J, Li X, Zhang D, Yan J, Zhang Y, Lu C, Xun J, Li W, Ling Y, Huang Y, Chen L. Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection. Aliment Pharmacol Ther 2017;45:701-13. [DOI: 10.1111/apt.13938] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
49 Liu H, Wang Y, Xing X, Sun Y, Wei D, Chen G, Liu Q, Chen S, Liu X, Liu J. Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials. Oncol Lett 2018;16:335-45. [PMID: 29928419 DOI: 10.3892/ol.2018.8666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Qin JM. Postoperative recurrent factors and therapeutic and preventive strategies for hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2019; 27(23): 1407-1418 [DOI: 10.11569/wcjd.v27.i23.1407] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Yang SL, Liu LP, Sun YF, Yang XR, Fan J, Ren JW, Chen GG, Lai PB. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis. J Gastroenterol 2016;51:722-32. [PMID: 26607653 DOI: 10.1007/s00535-015-1146-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
52 Meng H, Niu R, Huang C, Li J. Circular RNA as a Novel Biomarker and Therapeutic Target for HCC. Cells 2022;11:1948. [PMID: 35741077 DOI: 10.3390/cells11121948] [Reference Citation Analysis]
53 Obmann VC, Mertineit N, Berzigotti A, Marx C, Ebner L, Kreis R, Vermathen P, Heverhagen JT, Christe A, Huber AT. CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans. PLoS One 2018;13:e0199611. [PMID: 29990333 DOI: 10.1371/journal.pone.0199611] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Zhang W, Hu X, Wan N, Zhang J, Yang P, Wen Q, Chen W, Zhu F, Liang M, Cheng L, Shu Y. Protective effect of the glucagon-like peptide-1 analogue liraglutide on carbon tetrachloride-induced acute liver injury in mice. Biochemical and Biophysical Research Communications 2019;514:386-92. [DOI: 10.1016/j.bbrc.2019.04.160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
55 Zhang X, Gao X, Long G, Yang Y, Chen G, Hou G, Huo X, Jia J, Wang A, Hu G. Lanostane-type triterpenoids from the mycelial mat of Ganoderma lucidum and their hepatoprotective activities. Phytochemistry 2022. [DOI: 10.1016/j.phytochem.2022.113131] [Reference Citation Analysis]
56 Yang M, Wu E, Rao H, Du FH, Xie A, Cheng S, Rodd C, Lin A, Wei L, Lok AS. A Comparative Study of Liver Disease Care in the USA and Urban and Rural China. Dig Dis Sci 2016;61:2847-56. [PMID: 27256156 DOI: 10.1007/s10620-016-4206-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Chen F, Zhang K, Huang Y, Luo F, Hu K, Cai Q. SPC25 may promote proliferation and metastasis of hepatocellular carcinoma via p53. FEBS Open Bio 2020;10:1261-75. [PMID: 32351050 DOI: 10.1002/2211-5463.12872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
58 Su S, Fairley CK, Mao L, Medland N, Shen M, Li Y, Zhuang G, Zhang L. Estimation of the impact of changing drug-use trend on HIV, hepatitis C and syphilis epidemics among people who use synthetic drug-only, polydrug and heroin-only during 2005-2035 in China: modelling study. Sex Transm Infect 2020;96:608-14. [PMID: 32188771 DOI: 10.1136/sextrans-2019-054360] [Reference Citation Analysis]
59 He C, Peng W, Liu X, Li C, Li X, Wen TF. Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore). 2019;98:e16557. [PMID: 31374020 DOI: 10.1097/md.0000000000016557] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
60 Zhou L, He Q, Liu X, Yang X, Ou X, Situ B, Li Y, Pan X, Xu Q. Follow-Up of 108 Patients with Chronic Hepatitis B Virus Infection Treated with Polyethylene Glycol-Conjugated Derivatives of Interferon-Alpha and Monitoring of Off-Treatment Virological Relapse. Med Sci Monit 2022;28:e934785. [PMID: 35351845 DOI: 10.12659/MSM.934785] [Reference Citation Analysis]
61 Zhou SN, Zhang N, Liu HH, Xia P, Zhang C, Song JW, Fan X, Shi M, Jin L, Zhang JY, Wang FS. Skewed CD39/CD73/adenosine pathway contributes to B-cell hyperactivation and disease progression in patients with chronic hepatitis B. Gastroenterol Rep (Oxf) 2021;9:49-58. [PMID: 33747526 DOI: 10.1093/gastro/goaa048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Wei L, Lun Y, Zhou X, He S, Gao L, Liu Y, He Z, Li B, Wang C. Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo. Pharmacol Res 2019;143:73-85. [PMID: 30862605 DOI: 10.1016/j.phrs.2019.03.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
63 Liu N, Zhang J, Yang X, Jiao T, Zhao X, Li W, Zhu J, Yang P, Jin J, Peng J, Li Z, Ye X. HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function. J Virol. 2017;91. [PMID: 28592528 DOI: 10.1128/jvi.00340-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
64 Xu J, Hao J, Gao Y, Shang L, Qian L, Zhao H. Hepatic cortical blindness: a case report and comprehensive literature review. Am J Med Sci 2022:S0002-9629(22)00227-0. [PMID: 35595077 DOI: 10.1016/j.amjms.2022.04.034] [Reference Citation Analysis]
65 Bi S, Fu R, Li J, Chen Y, Tang Y. The Bioactivities and Potential Clinical Values of Angelica Sinensis Polysaccharides. Natural Product Communications 2021;16:1934578X2199732. [DOI: 10.1177/1934578x21997321] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Xu M, Zhou Z, Xu R, Zhang H, Lin N, Zhong Y. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis. World J Surg Oncol 2019;17:45. [PMID: 30823932 DOI: 10.1186/s12957-019-1577-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Zhu Z, Zhou W, Yang Y, Wang K, Li F, Dang Y. Quantitative Profiling of Oxylipin Reveals the Mechanism of Pien-Tze-Huang on Alcoholic Liver Disease. Evid Based Complement Alternat Med 2021;2021:9931542. [PMID: 34158817 DOI: 10.1155/2021/9931542] [Reference Citation Analysis]
68 Zhang NN, Lu CY, Shu GF, Li J, Chen MJ, Chen CM, Lv XL, Xu XL, Weng W, Weng QY, Tang BF, Du YZ, Ji JS. Gadolinium-loaded calcium phosphate nanoparticles for magnetic resonance imaging of orthotopic hepatocarcinoma and primary hepatocellular carcinoma. Biomater Sci 2020;8:1961-72. [PMID: 32064471 DOI: 10.1039/c9bm01544b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
69 Wu M, Zhao G, Zhuang X, Zhang T, Zhang C, Zhang W, Zhang Z. Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells. Onco Targets Ther 2018;11:2945-54. [PMID: 29849464 DOI: 10.2147/OTT.S165436] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
70 Leng XJ, Yan XB. Correlation between non-invasive liver stiffness measured by FibroTouch and serum markers in evaluating fibrosis degree in patients with chronic hepatitis B. Shijie Huaren Xiaohua Zazhi 2018; 26(12): 707-715 [DOI: 10.11569/wcjd.v26.i12.707] [Reference Citation Analysis]
71 Hou J, Hong Z, Feng F, Chai Y, Zhang Y, Jiang Q, Hu Y, Wu S, Wu Y, Gao X, Chen Q, Wan Y, Bi J, Zhang Z. A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma. BMC Cancer 2017;17:729. [PMID: 29117859 DOI: 10.1186/s12885-017-3706-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
72 Huang Y, Zeng J, Liu T, Lin X, Guo P, Zeng J, Zhou W, Liu J. Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma. Onco Targets Ther 2020;13:4559-67. [PMID: 32547086 DOI: 10.2147/OTT.S236475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Wang Y, Ding R, Zhang Z, Zhong C, Wang J, Wang M. Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma. Int J Pharm 2021;602:120628. [PMID: 33892061 DOI: 10.1016/j.ijpharm.2021.120628] [Reference Citation Analysis]
74 Li Y, Xu J, Li D, Ma H, Mu Y, Zheng D, Huang X, Li L. Chemical Characterization and Hepatoprotective Effects of a Standardized Triterpenoid-Enriched Guava Leaf Extract. J Agric Food Chem 2021;69:3626-37. [PMID: 33733770 DOI: 10.1021/acs.jafc.0c07125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Liu X, Li M, Wang X, Dang Z, Jiang Y, Wang X, Kong Y, Yang Z. PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Immunol Immunother 2019;68:2041-54. [PMID: 31720814 DOI: 10.1007/s00262-019-02426-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
76 Dong N, Chen WT, Bao M, Lu Y, Qian Y, Lu H. Self-Management Behaviors Among Patients With Liver Cirrhosis in Shanghai, China: A Cross-Sectional Study. Clin Nurs Res 2020;29:448-59. [PMID: 29806496 DOI: 10.1177/1054773818777914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
77 Zhang Y, Xu J, Wang X, Ren X, Liu Y. Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. BMC Genomics 2019;20:862. [PMID: 31726978 DOI: 10.1186/s12864-019-6251-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
78 Ahmad J, Wahab R, Siddiqui MA, Saquib Q, Ahmad N, Al-Khedhairy AA. Strontium-Doped Nickel Oxide Nanoparticles: Synthesis, Characterization, and Cytotoxicity Study in Human Lung Cancer A549 Cells. Biol Trace Elem Res 2021. [PMID: 34131861 DOI: 10.1007/s12011-021-02780-5] [Reference Citation Analysis]
79 Terefe Tesfaye B, Gudina EK, Bosho DD, Mega TA. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia. PLoS One 2019;14:e0221806. [PMID: 31469861 DOI: 10.1371/journal.pone.0221806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Zhang W, Wang X, Wang Y, Zhao X, Duan W, Wang Q, Wu X, Kong Y, Ma H, You H, Ou X, Jia J. Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up. Medicine (Baltimore) 2017;96:e8454. [PMID: 29095292 DOI: 10.1097/MD.0000000000008454] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
81 Chen H, Sun L, Feng L, Yin Y, Zhang W. Role of Innate lymphoid Cells in Obesity and Insulin Resistance. Front Endocrinol 2022;13:855197. [DOI: 10.3389/fendo.2022.855197] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 He M, Hou J, Wang L, Zheng M, Fang T, Wang X, Xia J. Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9. Oncotarget 2017;8:42136-48. [PMID: 28178673 DOI: 10.18632/oncotarget.15010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
83 Li L, Bi Y, Diao S, Li X, Yuan T, Xu T, Huang C, Li J. Exosomal LncRNAs and Hepatocellular Carcinoma: From Basic Research to Clinical Practice. Biochem Pharmacol 2022;:115032. [PMID: 35395241 DOI: 10.1016/j.bcp.2022.115032] [Reference Citation Analysis]
84 Qiu QT, Zhang J, Duan JH, Wu SZ, Ding JL, Yin Y. Development and validation of radiomics model built by incorporating machine learning for identifying liver fibrosis and early-stage cirrhosis. Chin Med J (Engl) 2020;133:2653-9. [PMID: 33009025 DOI: 10.1097/CM9.0000000000001113] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Gao B, Zhu Y, Gao N, Shen W, Stärkel P, Schnabl B. Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. Metabolites 2021;11:766. [PMID: 34822424 DOI: 10.3390/metabo11110766] [Reference Citation Analysis]
86 Anter AM, Bhattacharyya S, Zhang Z. Multi-stage fuzzy swarm intelligence for automatic hepatic lesion segmentation from CT scans. Applied Soft Computing 2020;96:106677. [DOI: 10.1016/j.asoc.2020.106677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
87 Zhang Z, Fan JG, Wang FS. Reply: To PMID 25164003. Hepatology 2015;62:1640-1. [PMID: 25722010 DOI: 10.1002/hep.27768] [Reference Citation Analysis]
88 Shen JY, Li C, Wen TF, Yan LN, Li B, Wang WT, Yang JY, Xu MQ, Nazar Highness T. Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis. Medicine (Baltimore) 2016;95:e5756. [PMID: 28033289 DOI: 10.1097/MD.0000000000005756] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
89 Li X, Liu Y, Guo X, Ma Y, Zhang H, Liang H. Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury. Eur J Clin Nutr 2021;75:1227-36. [PMID: 33514869 DOI: 10.1038/s41430-020-00852-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Niemelä O. Biomarker-Based Approaches for Assessing Alcohol Use Disorders. Int J Environ Res Public Health 2016;13:166. [PMID: 26828506 DOI: 10.3390/ijerph13020166] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 8.8] [Reference Citation Analysis]
91 Wang R, Chen K, Wang Y, Liu C, Wu Z, Wang D, Qu C. Booster immunization improves the generation of T follicular helper (Tfh) cells specific to hepatitis B surface antigen (HBsAg) after prenatal HBsAg exposure. Vaccine 2021;39:5571-9. [PMID: 34412920 DOI: 10.1016/j.vaccine.2021.08.020] [Reference Citation Analysis]
92 Shao QP, Wei C, Yang J, Zhang WZ. miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway. Onco Targets Ther 2020;13:7213-27. [PMID: 32801751 DOI: 10.2147/OTT.S246471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Nithyananthan S, Sushmaa D, Myrthong I, Valluru L, Guha S, Hassan Mir I, Behera J, Thirunavukkarasu C. Curcuma longa and Trigonella foenum graecum-enriched nutrient mixture from germinated Macrotyloma uniflorum and Vigna radiate ameliorate nonalcoholic fatty liver diseases in rats. J Food Biochem 2020;44:e13159. [PMID: 32017151 DOI: 10.1111/jfbc.13159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Xu Y, Liu Y, Cao Z, Wang L, Li Z, Sheng Z, Cai W, Wang H, Bao S, Xie Q. Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study. Dig Liver Dis 2019;51:1323-9. [PMID: 30928419 DOI: 10.1016/j.dld.2019.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
95 Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, Xu Y, Liu Y, Li W, Koike K, He W, You H, Miao Y, Liu X, Meng M, Gao B, Wang H, Li C. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol. 2019;71:212-221. [PMID: 30871980 DOI: 10.1016/j.jhep.2019.03.004] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 30.0] [Reference Citation Analysis]
96 Iwakiri Y, Nathanson MH. Alcohol and calcium make a potent cocktail. J Physiol 2017;595:3109-10. [PMID: 28295353 DOI: 10.1113/JP274133] [Reference Citation Analysis]
97 Lin D, Sun Z, Jin Z, Lei L, Liu Y, Hu B, Wang B, Shen Y, Wang Y. Matrix Remodeling Associated 7 Deficiency Alleviates Carbon Tetrachloride-Induced Acute Liver Injury in Mice. Front Immunol 2018;9:773. [PMID: 29720975 DOI: 10.3389/fimmu.2018.00773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
98 Wang S, Jiang J, Zhang C, Zhang X, Wang C. Serum lincRNA-p21 expression in primary liver diseases and liver metastatic diseases. Pathology - Research and Practice 2019;215:779-83. [DOI: 10.1016/j.prp.2019.01.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
99 Sun H, Feng F, Xie H, Li X, Jiang Q, Chai Y, Wang Z, Yang R, Li R, Hou J. Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model. Animal Model Exp Med 2019;2:259-68. [PMID: 31942558 DOI: 10.1002/ame2.12085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
100 Wu L, Yang Z, Zhang J, Xie H, Zhou L, Zheng S. Long noncoding RNA HOTTIP expression predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Hepatobiliary Surg Nutr 2018;7:429-39. [PMID: 30652087 DOI: 10.21037/hbsn.2018.10.07] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
101 Liu X, Xu J. Calling a stage-based treatment model for chronic liver diseases in China mainland. Ann Hepatol 2020;19:585-9. [PMID: 31711913 DOI: 10.1016/j.aohep.2019.09.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Cao Z, Li Z, Wang Y, Liu Y, Mo R, Ren P, Chen L, Lu J, Li H, Zhuang Y, Liu Y, Wang X, Zhao G, Tang W, Xiang X, Wang H, Cai W, Liu L, Zhu C, Bao S, Xie Q. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection. J Viral Hepat. 2017;24 Suppl 1:57-65. [PMID: 29082644 DOI: 10.1111/jvh.12786] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
103 Zhang C, Wang P, Li Y, Huang C, Ni W, Chen Y, Shi J, Chen G, Hu X, Ye M, Duan S, Wang K. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. Anat Rec (Hoboken) 2019;302:193-200. [PMID: 30312023 DOI: 10.1002/ar.23954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
104 Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 2020;71:1851-64. [PMID: 32012320 DOI: 10.1002/hep.31150] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 56.5] [Reference Citation Analysis]
105 Zhu G, Liao X, Han C, Liu X, Yu L, Qin W, Lu S, Su H, Chen Z, Liu Z, Liang Y, Huang J, Yu T, Yang C, Huang K, Shang L, Ye X, Li L, Qin X, Xiao K, Peng M, Peng T. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma. Oncol Rep 2017;38:1451-63. [PMID: 28714006 DOI: 10.3892/or.2017.5822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
106 Zheng W, Jiang F, Shan J, Wang Y, Jia Y, Guo Q, Lou J, Zhao Y. Levels of serum IgG subclasses in patients with liver disease: A retrospective study. Exp Ther Med 2021;21:45. [PMID: 33273974 DOI: 10.3892/etm.2020.9476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Xue R, Li R, Guo H, Guo L, Su Z, Ni X, Qi L, Zhang T, Li Q, Zhang Z, Xie XS, Bai F, Zhang N. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150:998-1008. [PMID: 26752112 DOI: 10.1053/j.gastro.2015.12.033] [Cited by in Crossref: 105] [Cited by in F6Publishing: 111] [Article Influence: 17.5] [Reference Citation Analysis]
108 Zhao Q, Liu YY, Lei X, Lei FF, Li G, Li F, Li JK, Yang J, Liu L, Tan HB. PIVKA-Ⅱ as a screening marker for hepatocellular carcinoma in patients with hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2017; 25(9): 803-809 [DOI: 10.11569/wcjd.v25.i9.803] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Guo X, Wu J, Wei F, Ouyang Y, Li Q, Liu K, Wang Y, Zhang Y, Chen D. Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study. Int J Antimicrob Agents 2018;52:201-9. [PMID: 29654894 DOI: 10.1016/j.ijantimicag.2018.04.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
110 Xu T, Wang P, Zheng X, Yan Z, Li K, Xu J, Jiang C, Zhu F. The therapeutic effects and mechanisms of Long Chai Fang on chronic hepatitis B. Ann Transl Med 2021;9:865. [PMID: 34164499 DOI: 10.21037/atm-21-1923] [Reference Citation Analysis]
111 Lu J, Zhang C, He P, Ou M, Xia J, Huang M. Risk factors for very low-level viremia in patients with chronic hepatitis B virus infection: A single-center retrospective study. Liver Research 2022. [DOI: 10.1016/j.livres.2022.02.001] [Reference Citation Analysis]
112 Shen D, Hu W, Zhao S, Mao C. Rapid Naked-Eye Detection of a Liver Disease Biomarker by Discovering Its Monoclonal Antibody to Functionalize Engineered Red-Colored Bacteria Probes. ACS Omega 2021;6:32005-10. [PMID: 34870023 DOI: 10.1021/acsomega.1c04779] [Reference Citation Analysis]
113 Zhu J, Zhang T, Cao L, Li A, Zheng K, Zhang N, Su B, Chen Z, Chen N, Wu H, He Q. Toll like receptor7 polymorphisms in relation to disease susceptibility and progression in Chinese patients with chronic HBV infection. Sci Rep 2017;7:12417. [PMID: 28963470 DOI: 10.1038/s41598-017-12698-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
114 Zeng T, Wang D, Chen J, Chen K, Yu G, Chen Q, Liu Y, Yan S, Zhu L, Zhou H, Huang A, Tang H. AF119895 regulates NXF3 expression to promote migration and invasion of hepatocellular carcinoma through an interaction with miR-6508-3p. Exp Cell Res 2018;363:129-39. [PMID: 29274323 DOI: 10.1016/j.yexcr.2017.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
115 Xiao LL, Wu XX, Chen JJ, Yan D, Shi DY, Huang JR, Xu XW, Li LJ. Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: A large, multicenter, retrospective cohort study using a propensity score matching analysis. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00119-3. [PMID: 34303609 DOI: 10.1016/j.hbpd.2021.05.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Li H, Xu QY, Xie Y, Luo JJ, Cao HX, Pan Q. Effects of chronic HBV infection on lipid metabolism in non-alcoholic fatty liver disease: A lipidomic analysis. Ann Hepatol. 2021;24:100316. [PMID: 33515803 DOI: 10.1016/j.aohep.2021.100316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
117 Wei L, Li J, Yang X, Wang G, Feng B, Hou J, Duan Z, Jia J, Ren H, Niu J, Chen X, Wang F, Shang J, Bo Q, Li R, Liu Y, Zhuang H. Nationwide survey of specialist knowledge on current standard of care (Peg‐IFN/RBV) and barriers of care in chronic hepatitis C patients in China. Journal of Gastroenterology and Hepatology 2016;31:1995-2003. [DOI: 10.1111/jgh.13399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
118 Wang L, Wang FS. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges. Hepatol Int 2019;13:521-33. [PMID: 31352593 DOI: 10.1007/s12072-019-09967-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
119 Sharma R. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Jpn J Clin Oncol 2020;50:1370-9. [PMID: 32719873 DOI: 10.1093/jjco/hyaa130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
120 Shen JY, Li C, Wen TF, Yan LN, Li B, Wang WT, Yang JY, Xu MQ. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. J Surg Res. 2017;209:102-111. [PMID: 28032546 DOI: 10.1016/j.jss.2016.10.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
121 Li BY, Li HY, Zhou DD, Huang SY, Luo M, Gan RY, Mao QQ, Saimaiti A, Shang A, Li HB. Effects of Different Green Tea Extracts on Chronic Alcohol Induced-Fatty Liver Disease by Ameliorating Oxidative Stress and Inflammation in Mice. Oxid Med Cell Longev 2021;2021:5188205. [PMID: 35003517 DOI: 10.1155/2021/5188205] [Reference Citation Analysis]
122 Zhuo JY, Lu D, Lin ZY, Cen BN, Wei XY, Xie HY, Zheng SS, Xu X. CC motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells. Hepatobiliary Pancreat Dis Int 2020;19:440-8. [PMID: 31948840 DOI: 10.1016/j.hbpd.2019.12.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Cui X, Lin Z, Chen Y, Mao X, Ni W, Liu J, Zhou H, Shan X, Chen L, Lv J, Shen Z, Duan C, Hu B, Ni R. Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem 2016;421:127-37. [DOI: 10.1007/s11010-016-2793-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
124 Guo J, Fu W, Xiang M, Zhang Y, Zhou K, Xu CR, Li L, Kuang D, Ye F. Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma. Curr Med Sci 2019;39:929-37. [PMID: 31845224 DOI: 10.1007/s11596-019-2125-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Zeng QL, Zhang HX, Zhang JY, Huang S, Li WZ, Li GM, Pan YJ, Feng YH, Li ZQ, Zhang GF, Xu JH, Lin WB, Xu GH, Liu N, Zhang GQ, Li GT, Li W, Zeng YL, Song N, Wang M, Zhang DW, Chen ZM, Cui GL, Li J, Lv J, Liu YM, Liang HX, Sun CY, Zhou YH, Yu ZJ, Wang FS. Tenofovir Alafenamide for Pregnant Chinese Women with Active Chronic Hepatitis B: A Multicenter Prospective Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01306-9. [PMID: 34902570 DOI: 10.1016/j.cgh.2021.12.012] [Reference Citation Analysis]
126 Shi A, Shi H, Wang Y, Liu X, Cheng Y, Li H, Zhao H, Wang S, Dong L. Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury. Int Immunopharmacol 2018;54:125-30. [PMID: 29128856 DOI: 10.1016/j.intimp.2017.11.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
127 Wei X, Yang D, Xing Z, Zhao C, Wang L, Fan Y, Nie H, Liu H. Quercetin loaded liposomes modified with galactosylated chitosan prevent LPS/D-GalN induced acute liver injury. Mater Sci Eng C Mater Biol Appl 2021;131:112527. [PMID: 34857306 DOI: 10.1016/j.msec.2021.112527] [Reference Citation Analysis]
128 Zhao L, Chen S, Shi X, Cao H, Li L. A pooled analysis of mesenchymal stem cell-based therapy for liver disease. Stem Cell Res Ther. 2018;9:72. [PMID: 29562935 DOI: 10.1186/s13287-018-0816-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
129 Tian M, Wang B, Xue Z, Dong D, Liu X, Wu R, Yu L, Xiang J, Zhang X, Zhang X, Lv Y. Telemedicine for Follow-up Management of Patients After Liver Transplantation: Cohort Study. JMIR Med Inform 2021;9:e27175. [PMID: 33999008 DOI: 10.2196/27175] [Reference Citation Analysis]
130 Hu Y, Ciyang, Dunzhuyongzong, Awangluosong, Yang Z, Aqing. Seroepidemiology of hepatitis B virus infection in children 12 years after China's expanded program on immunization in Qamdo, Tibet. J Public Health Policy 2018;39:446-53. [PMID: 30089882 DOI: 10.1057/s41271-018-0142-z] [Reference Citation Analysis]
131 Xue C, Gu X, Li G, Bao Z, Li L. Mitochondrial Mechanisms of Necroptosis in Liver Diseases. Int J Mol Sci 2020;22:E66. [PMID: 33374660 DOI: 10.3390/ijms22010066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y, Qi L, Liu Y, Wu Q, Cui Y, Fang F, Zhang X, Song T, Guo H. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018;9:513. [PMID: 29725020 DOI: 10.1038/s41419-018-0534-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 82] [Article Influence: 17.8] [Reference Citation Analysis]
133 Bagheri Lankarani K, Honarvar B, Rouhezamin MR, Raeisi Shahraki H, Seifi V, Geramizadeh B, Salahi H, Nikeghbalian S, Shamsaeefar A, Keshani P, Malekhosseini SA. Mortality and Its Determinants in Adult Patients with End-stage Liver Disease on Waiting List for Liver Transplantation: A Preliminary Report on Baseline Data. Shiraz E-Med J 2021;22. [DOI: 10.5812/semj.110254] [Reference Citation Analysis]
134 Shang J, Zhou J, Liu H, Ise RM, Tu Y, Ran J, Bai L, Tang H. Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients. BMC Infect Dis 2021;21:912. [PMID: 34488678 DOI: 10.1186/s12879-021-06554-1] [Reference Citation Analysis]
135 Jiang S, Wang X, Chen K, Yang P. Establishment of an inducible cell line for Hepatitis B virus genotype C2 and its pharmacological responses to interferons. Pharmacol Res 2022;:106142. [PMID: 35218895 DOI: 10.1016/j.phrs.2022.106142] [Reference Citation Analysis]
136 Zhu C, Qi X, Li H, Peng Y, Dai J, Chen J, Xia C, Hou Y, Zhang W, Guo X. Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study. Int J Clin Exp Med 2015;8:5989-98. [PMID: 26131195] [Reference Citation Analysis]
137 Zhou D, Pan Q, Xin FZ, Zhang RN, He CX, Chen GY, Liu C, Chen YW, Fan JG. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World J Gastroenterol 2017; 23(1): 60-75 [PMID: 28104981 DOI: 10.3748/wjg.v23.i1.60] [Cited by in CrossRef: 127] [Cited by in F6Publishing: 113] [Article Influence: 25.4] [Reference Citation Analysis]
138 Li H, Wang R, Méndez-Sánchez N, Peng Y, Guo X, Qi X. Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. Arch Med Sci 2019;15:434-48. [PMID: 30899297 DOI: 10.5114/aoms.2018.74788] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
139 shen J, Li C, Wen T, Yan L, Li B, Wang W, Yang J, Xu M, wen J. Transplantation versus hepatectomy for HCC beyond the Milan criteria: A propensity score analysis. International Journal of Surgery 2017;44:33-42. [DOI: 10.1016/j.ijsu.2017.05.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
140 Zhou D, Li BH, Wang J, Ding YN, Dong Y, Chen YW, Fan JG. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. PLoS One 2016;11:e0165224. [PMID: 27760195 DOI: 10.1371/journal.pone.0165224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
141 Wei J, Sun Z, Shi L, Hu S, Liu D, Wei H. Molecular Mechanism of Chrysin in Hepatocellular Carcinoma Treatment Based on Network Pharmacology and in Vitro Experiments. Natural Product Communications 2021;16:1934578X2110672. [DOI: 10.1177/1934578x211067294] [Reference Citation Analysis]
142 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
143 Huang R, Fan JG, Shi JP, Mao YM, Wang BY, Zhao JM, Lu LG, Zhong BH, Zou ZS, Xu YQ, Ye YN, Liu LG, Lin LJ, Li JP, Rao HY, Wei L. Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey. Health Qual Life Outcomes 2021;19:140. [PMID: 33962617 DOI: 10.1186/s12955-021-01778-w] [Reference Citation Analysis]
144 Phaosri M, Jantrapirom S, Takuathung MN, Soonthornchareonnon N, Sireeratawong S, Buacheen P, Pitchakarn P, Nimlamool W, Potikanond S. Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells Through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling Pathway. Int J Mol Sci 2019;20:E6314. [PMID: 31847284 DOI: 10.3390/ijms20246314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
145 Seto W, Yuen M. Hepatitis B Virus: Asian Perspective. In: Wong RJ, Gish RG, editors. Clinical Epidemiology of Chronic Liver Diseases. Cham: Springer International Publishing; 2019. pp. 99-116. [DOI: 10.1007/978-3-319-94355-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
146 Fan H, Lin L, Jia S, Xie M, Luo C, Tan X, Ying R, Guan Y, Li F. Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B. J Viral Hepat 2019;26:77-84. [DOI: 10.1111/jvh.13165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
147 Rao H, Wu E, Fu S, Yang M, Feng B, Lin A, Fei R, Fontana RJ, Lok AS, Wei L. The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease. Aliment Pharmacol Ther 2017;46:731-40. [PMID: 28833342 DOI: 10.1111/apt.14273] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
148 Wang M, Yuan F, Bai H, Zhang J, Wu H, Zheng K, Zhang W, Miao M, Gong J. SHMT2 Promotes Liver Regeneration Through Glycine-activated Akt/mTOR Pathway. Transplantation 2019;103:e188-97. [PMID: 30964837 DOI: 10.1097/TP.0000000000002747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
149 Yang K, Zhu H, Chen CC, Wen TF, Zhang WH, Liu K, Chen XZ, Guo DJ, Zhou ZG, Hu JK. Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review. Medicine (Baltimore) 2016;95:e2666. [PMID: 26886605 DOI: 10.1097/MD.0000000000002666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
150 Tao H, Guo J, Ma Y, Zhao Y, Jin T, Gu L, Dou Y, Liu J, Hu H, Xiong X, Zhang J. Luminescence Imaging of Acute Liver Injury by Biodegradable and Biocompatible Nanoprobes. ACS Nano 2020;14:11083-99. [PMID: 32790342 DOI: 10.1021/acsnano.0c00539] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
151 Wang YJ, Li JH, Guan Y, Xie QH, Hao CM, Wang ZX. Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients. Hepatobiliary Pancreat Dis Int 2021;20:215-21. [PMID: 33752999 DOI: 10.1016/j.hbpd.2021.02.006] [Reference Citation Analysis]
152 Li X, Han QC, Yu C, Luo YC, Wang F, Sun XH, Gao YQ, Tan WF, Xia Q. C-C chemokine hepatocellular carcinoma motif ligand 5-deficiency promotes hepatocellular carcinoma progression by affecting B cell recruitment. J Dig Dis 2021;22:433-41. [PMID: 33978316 DOI: 10.1111/1751-2980.12997] [Reference Citation Analysis]
153 Liu Y, Zhou Y, Li X, Niu M, Chen R, Shao J, Si L, Luo D, Lin Y, Li L, Zhang K, Xiao X, Xu Z, Liu M, Lu M, Zoulim F, Xu D. Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice. Emerg Microbes Infect. 2019;8:354-365. [PMID: 30866789 DOI: 10.1080/22221751.2019.1584018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
154 Zhang Y, Bi M, Chen Z, Dai M, Zhou G, Hu Y, Yang H, Guan W. Hydrogen gas alleviates acute alcohol-induced liver injury by inhibiting JNK activation. Exp Ther Med 2021;21:453. [PMID: 33767761 DOI: 10.3892/etm.2021.9884] [Reference Citation Analysis]
155 Peng WX, Xiong EM, Ge L, Wan YY, Zhang CL, Du FY, Xu M, Bhat RA, Jin J, Gong AH. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells. Exp Cell Res 2016;340:62-70. [PMID: 26708617 DOI: 10.1016/j.yexcr.2015.12.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
156 Chand SK, Pendharkar SA, Bharmal SH, Bartlett AS, Pandol SJ, Petrov MS. Frequency and risk factors for liver disease following pancreatitis: A population-based cohort study. Dig Liver Dis 2019;51:551-8. [PMID: 30522894 DOI: 10.1016/j.dld.2018.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
157 Zhao D, Cui H, Shao Z, Liying C. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Ann Hepatol 2022;:100726. [PMID: 35636732 DOI: 10.1016/j.aohep.2022.100726] [Reference Citation Analysis]
158 Wang Q, Li H, Ding D, Peng M, Ren H, Hu P. Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-life Study. J Clin Transl Hepatol 2018;6:11-7. [PMID: 29577027 DOI: 10.14218/JCTH.2017.00020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Shen X, Jin C, Wu Y, Zhang Y, Wang X, Huang W, Li J, Wu S, Gao X. Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease. J Hum Nutr Diet 2019;32:802-9. [PMID: 31209928 DOI: 10.1111/jhn.12674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
160 Li M, Chen Z, Xu L, Gan Z, Peng F, Liu J. A Comparison of the Clinical Characteristics and Outcomes of Cryptococcal Meningitis in HIV-negative Individuals With and Without Immunosuppression. Neurologist 2019;24:1-5. [PMID: 30586025 DOI: 10.1097/NRL.0000000000000221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
161 Niu C, Liu Y, Wang J, Liu Y, Zhang S, Zhang Y, Zhang L, Zhao D, Liu F, Chao L, Wang X, Zhang C, Song G, Zhang Z, Li Y, Yan Z, Wen Y, Ge Y, Zang Z, Feng W, Zhang H, Tao L, Nakyeyune R, Shen Y, Shao Y, Guo X, Miles T, Yang A, Liu F, Wang G. Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study. BMC Cancer 2021;21:1034. [PMID: 34530751 DOI: 10.1186/s12885-021-08764-x] [Reference Citation Analysis]
162 Attallah NGM, Mokhtar FA, Elekhnawy E, Heneidy SZ, Ahmed E, Magdeldin S, Negm WA, El-kadem AH. Mechanistic Insights on the In Vitro Antibacterial Activity and In Vivo Hepatoprotective Effects of Salvinia auriculata Aubl against Methotrexate-Induced Liver Injury. Pharmaceuticals 2022;15:549. [DOI: 10.3390/ph15050549] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Ullah H, Khan A, Rehman NU, Halim SA, Khan H, Khan I, Csuk R, Al-Rawahi A, Al-Hatmi S, Al-Harrasi A. Lophenol and lathosterol from resin of Commiphora kua possess hepatoprotective effects in vivo. J Ethnopharmacol 2020;252:112558. [PMID: 31926985 DOI: 10.1016/j.jep.2020.112558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Dai J, Zhu X, Shen J, Zhang Y, Xie F, Yu Y, Jiang K, Wen T, Li C. The Effect of Metabolic Syndrome on the Outcome of Hepatitis B-Associated Hepatocellular Carcinoma Patients After Hepatectomy: A Multicenter Study. Front Oncol 2022;12:811084. [PMID: 35356224 DOI: 10.3389/fonc.2022.811084] [Reference Citation Analysis]
165 Liu X, Zhang ZH, Jiang F. Hepatitis B virus infection increases the risk of pancreatic cancer: a meta-analysis. Scand J Gastroenterol 2021;56:252-8. [PMID: 33399501 DOI: 10.1080/00365521.2020.1868568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Kuo YT, Chen CY, Liu GC, Wang YM. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model. PLoS One 2016;11:e0148695. [PMID: 26886558 DOI: 10.1371/journal.pone.0148695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
167 Yang RX, Pan Q, Liu XL, Zhou D, Xin FZ, Zhao ZH, Zhang RN, Zeng J, Qiao L, Hu CX, Xu GW, Fan JG. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. Lipids Health Dis 2019;18:179. [PMID: 31639005 DOI: 10.1186/s12944-019-1118-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
168 Zhang W, Yang Z, Niu Y, Li X, Zhu L, Lu S, Zhang H, Fan J, Ning G, Qin L, Su Q. Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study. BMC Endocr Disord 2017;17:28. [PMID: 28558676 DOI: 10.1186/s12902-017-0176-4] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
169 Shao Z, Li Y, Dai W, Jia H, Zhang Y, Jiang Q, Chai Y, Li X, Sun H, Yang R, Cao Y, Feng F, Guo Y. ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR. Pharmacol Res 2018;135:188-200. [PMID: 30114438 DOI: 10.1016/j.phrs.2018.08.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
170 Li J. Digestive cancer incidence and mortality among young adults worldwide in 2020: A population-based study. World J Gastrointest Oncol 2022;14:278-94. [PMID: 35116117 DOI: 10.4251/wjgo.v14.i1.278] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Zhang Z, Gao B, Wang FS. Reply. Hepatology 2016;63:348. [PMID: 25953045 DOI: 10.1002/hep.27879] [Reference Citation Analysis]
172 Han J, Li Z, Xing H, Wu H, Zhu P, Lau WY, Zhou Y, Gu W, Wang H, Chen T, Zeng Y, Wu M, Shen F, Yang T. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. HPB 2019;21:962-71. [DOI: 10.1016/j.hpb.2018.11.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
173 Shi GY, Pan YJ, Jiang K, Xie JD. Efficacy of different antiviral treatments for chronic hepatitis B patients carrying different genotypes of hepatitis B virus. Shijie Huaren Xiaohua Zazhi 2016; 24(35): 4704-4709 [DOI: 10.11569/wcjd.v24.i35.4704] [Reference Citation Analysis]
174 Xie H, Yu H, Tian S, Yang X, Wang X, Wang H, Guo Z. MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation. Oncotarget 2018;9:15252-65. [PMID: 29632641 DOI: 10.18632/oncotarget.24165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
175 Vo Quang E, Shimakawa Y, Nahon P. Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination. Liver Int 2021;41:915-27. [PMID: 33641230 DOI: 10.1111/liv.14843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
176 Burra P, Shalaby S, Zanetto A. Long-term care of transplant recipients: De novo neoplasms after liver transplantation. Curr Opin Organ Transplant. 2018;23:187-195. [PMID: 29324517 DOI: 10.1097/mot.0000000000000499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
177 Li H, Wang H, Peng C, Zheng X, Liu J, Weng ZH, Yang DL. Predictors for efficacy of combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B. J Huazhong Univ Sci Technolog Med Sci 2017;37:547-55. [PMID: 28786051 DOI: 10.1007/s11596-017-1771-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
178 Wang Y, Liu H, Liang D, Huang Y, Zeng Y, Xing X, Xia J, Lin M, Han X, Liao N, Liu X, Liu J. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics. J Proteomics 2017;150:230-41. [PMID: 27693406 DOI: 10.1016/j.jprot.2016.09.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
179 Zheng W, Yang Y, Sequeira RC, Bishop CE, Atala A, Gu Z, Zhao W. Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases. Curr Stem Cell Res Ther 2019;14:442-52. [PMID: 30854976 DOI: 10.2174/1574888X14666190308123714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Zahran RF, Geba ZM, Tabll AA, Mashaly MM. Therapeutic potential of a novel combination of Curcumin with Sulfamethoxazole against carbon tetrachloride-induced acute liver injury in Swiss albino mice. J Genet Eng Biotechnol 2020;18:13. [PMID: 32363509 DOI: 10.1186/s43141-020-00027-9] [Reference Citation Analysis]
181 Shi H, Huang M, Lin G, Li X, Wu Y, Jie Y, Chong Y. Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA. Biomed Res Int 2016;2016:6725073. [PMID: 27034945 DOI: 10.1155/2016/6725073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
182 Chen B, Gu Y, Shen H, Liu Q, Wang H, Li Y, Liu X, Liu Y, Du Q, Sun H, Liao X. Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma. JHC 2022;Volume 9:171-88. [DOI: 10.2147/jhc.s336452] [Reference Citation Analysis]
183 Wei Z, Ren Z, Hu S, Gao Y, Sun R, Lv S, Yang G, Yu Z, Kan Q. Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease. Cancer Med 2020;9:1254-62. [PMID: 31860170 DOI: 10.1002/cam4.2777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
184 Ling S, Jiang G, Que Q, Xu S, Chen J, Xu X. Liver transplantation in patients with liver failure: twenty years of experience from China. Liver Int 2022. [PMID: 35532977 DOI: 10.1111/liv.15288] [Reference Citation Analysis]
185 Shan L, Liu Z, Ci L, Shuai C, Lv X, Li J. Research progress on the anti-hepatic fibrosis action and mechanism of natural products. Int Immunopharmacol 2019;75:105765. [PMID: 31336335 DOI: 10.1016/j.intimp.2019.105765] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
186 Zhu H, Ge K, Lu J, Jia C. Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease. Gut Liver 2020;14:492-9. [PMID: 31694365 DOI: 10.5009/gnl19115] [Reference Citation Analysis]
187 Pang Y, Kartsonaki C, Lv J, Millwood IY, Yu C, Guo Y, Chen Y, Bian Z, Yang L, Chen J, Clarke R, Walters R, Wu S, Li H, Holmes MV, Li L, Chen Z. Observational and Genetic Associations of Body Mass Index and Hepatobiliary Diseases in a Relatively Lean Chinese Population. JAMA Netw Open 2020;3:e2018721. [PMID: 33006619 DOI: 10.1001/jamanetworkopen.2020.18721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
188 Çalışkan M, Manduchi E, Rao HS, Segert JA, Beltrame MH, Trizzino M, Park Y, Baker SW, Chesi A, Johnson ME, Hodge KM, Leonard ME, Loza B, Xin D, Berrido AM, Hand NJ, Bauer RC, Wells AD, Olthoff KM, Shaked A, Rader DJ, Grant SFA, Brown CD. Genetic and Epigenetic Fine Mapping of Complex Trait Associated Loci in the Human Liver. Am J Hum Genet 2019;105:89-107. [PMID: 31204013 DOI: 10.1016/j.ajhg.2019.05.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
189 Ma Z, Zhang B, Fan Y, Wang M, Kebebe D, Li J, Liu Z. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomed Pharmacother 2019;117:109128. [PMID: 31234023 DOI: 10.1016/j.biopha.2019.109128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
190 Shen Y, Zhang J, Cai H, Shao JG, Zhang YY, Liu YM, Qin G, Qin Y. Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls. BMC Gastroenterol. 2015;15:32. [PMID: 25887997 DOI: 10.1186/s12876-015-0263-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
191 Guo X, Chen P, Hou X, Xu W, Wang D, Wang TY, Zhang L, Zheng G, Gao ZL, He CY, Zhou B, Chen ZY. The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely. Sci Rep 2016;6:25552. [PMID: 27174254 DOI: 10.1038/srep25552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
192 Ning NZ, Li T, Zhang JL, Qu F, Huang J, Liu X, Li Z, Geng W, Fu JL, Huan W, Zhang SY, Bao CM, Wang H. Clinical and bacteriological features and prognosis of ascitic fluid infection in Chinese patients with cirrhosis. BMC Infect Dis 2018;18:253. [PMID: 29866104 DOI: 10.1186/s12879-018-3101-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
193 Zahran RF, Geba ZM, Tabll AA, Mashaly MM. Therapeutic potential of a novel combination of Curcumin with Sulfamethoxazole against carbon tetrachloride-induced acute liver injury in Swiss albino mice. J Genet Eng Biotechnol 2020;18:13. [PMID: 32363509 DOI: 10.1186/s43141-020-00027-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
194 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
195 Hou J, Wang G, Wang F, Cheng J, Ren H, Zhuang H, Sun J, Li L, Li J, Meng Q, Zhao J, Duan Z, Jia J, Tang H, Sheng J, Peng J, Lu F, Xie Q, Wei L; Chinese Society of Hepatology, Chinese Medical Association., Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). J Clin Transl Hepatol 2017;5:297-318. [PMID: 29226097 DOI: 10.14218/JCTH.2016.00019] [Cited by in Crossref: 109] [Cited by in F6Publishing: 59] [Article Influence: 21.8] [Reference Citation Analysis]
196 Kang Y, Li Y, Xu F, Zhang J, Wang K, Chen Y, Wu J, Guo B, Yu J, Zhang Y. Population Pharmacokinetics Study of Nemonoxacin Among Chinese Patients With Moderate Hepatic Impairment. Clinical Therapeutics 2019;41:505-517.e0. [DOI: 10.1016/j.clinthera.2019.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Mao QG, Liang HQ, Yin YL, Tang JM, Yang JE, Wu CC, Chen Y, Zhang MY, Liu YY, Zheng XT, Zhuang LY, Chen SD. Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B. Clin Res Hepatol Gastroenterol 2021;:101758. [PMID: 34303003 DOI: 10.1016/j.clinre.2021.101758] [Reference Citation Analysis]
198 Shao S, Sun J, Liu CY, Dong HJ, Li YQ, Gao YH. Aldehyde dehydrogenase 2 gene polymorphisms and liver diseases. Shijie Huaren Xiaohua Zazhi 2017; 25(33): 2981-2986 [DOI: 10.11569/wcjd.v25.i33.2981] [Reference Citation Analysis]
199 Chang B, Li B, Huang A, Sun Y, Teng G, Wang X, Liangpunsakul S, Li J, Zou Z. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013. Alcohol 2016;54:61-5. [PMID: 27519542 DOI: 10.1016/j.alcohol.2016.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
200 Liao X, Li D, Ma Z, Zhang L, Zheng B, Li Z, Li G, Liu L, Zhang Z. 12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19: A Single-Center Prospective Cohort Study. Front Cell Infect Microbiol 2022;12:864933. [DOI: 10.3389/fcimb.2022.864933] [Reference Citation Analysis]
201 Lu HY, Chu HX, Tan YX, Qin XC, Liu MY, Li JD, Ren TS, Zhang YS, Zhao QC. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Life Sci 2020;244:117343. [PMID: 31978449 DOI: 10.1016/j.lfs.2020.117343] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
202 Xiong Y, Huang J. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment. Chin Med 2021;16:80. [PMID: 34407830 DOI: 10.1186/s13020-021-00489-0] [Reference Citation Analysis]
203 Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M. Prevalence of HBsAg/HBeAg amongst 1 936 801 couples preparing for pregnancy in rural China: An observational study. J Viral Hepat 2017;24:679-86. [DOI: 10.1111/jvh.12693] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
204 Dong Y, Qiu P, Zhao L, Zhang P, Huang X, Li C, Chai K, Shou D. Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis.Phytomedicine. 2020;74:152697. [PMID: 30392748 DOI: 10.1016/j.phymed.2018.09.232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
205 Lin K, Huang Q, Huo Y, Zeng J, Ding Z, Guo P, Chen Z, Zeng Y, Liu J. Development and Validation of a Prognostic Nomogram to Predict the Long-Time Prognosis in Non-B, Non-C Hepatocellular Carcinoma. Cancer Manag Res 2020;12:7771-81. [PMID: 32943923 DOI: 10.2147/CMAR.S257016] [Reference Citation Analysis]
206 Chen Y, Wang Y, Chen Y, Yu Z, Chi X, Hu KQ, Li Q, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chi W, Dong Z, Wang X, Li Z, Xiao H, Chen D, Bai W, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Sun H, Deng M, Qi X, Zhang Z, Qi X, Yang Y. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B. Clin Transl Gastroenterol 2019;10:1-12. [PMID: 31033506 DOI: 10.14309/ctg.0000000000000033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
207 Ding J, Wang H. ψ-Bufarenogin, a lead compound of anti-cancer drug. Cell Cycle 2015;14:2719-20. [PMID: 26312642 DOI: 10.1080/15384101.2015.1071139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
208 Shi T, Yu L, Zhuang R, Xi J, He R, Shao Y, Huang J, Liu S, Yang X. Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease. Can J Gastroenterol Hepatol 2021;2021:5527315. [PMID: 34222135 DOI: 10.1155/2021/5527315] [Reference Citation Analysis]
209 Ge X, Sun T, Zhang Y, Li Y, Gao P, Zhang D, Zhang B, Wang P, Ma W, Lu S. The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease. Nutr Metab (Lond) 2022;19:3. [PMID: 35016686 DOI: 10.1186/s12986-021-00634-4] [Reference Citation Analysis]
210 Gao M, Feng C, Ying R, Nie Y, Deng X, Zhu Y, Tang X, Guan Y, Hu F, Li F. A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum. Arch Virol. 2019;164:2683-2690. [PMID: 31428915 DOI: 10.1007/s00705-019-04372-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
211 Ke SH, Zheng CH, Peng C, Zhou Y, Ma W. Establishment of a rat model of non-alcoholic fatty liver disease combined with type 2 diabetes. Shijie Huaren Xiaohua Zazhi 2018; 26(31): 1805-1811 [DOI: 10.11569/wcjd.v26.i31.1805] [Reference Citation Analysis]
212 Qi X, Liu F, Li Z, Chen S, Liu Y, Yang Y, Hou J; Chinese Portal Hypertension Noninvasive Diagnosis Study (CHESS) Group. Insufficient accuracy of computed tomography-based portal pressure assessment in hepatitis B virus-related cirrhosis: An analysis of data from CHESS-1601 trial. J Hepatol 2017:S0168-8278(17)32277-8. [PMID: 28887165 DOI: 10.1016/j.jhep.2017.07.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
213 Tian J, Tan F, Lai L, Deng Y, Chi X, Geng H, Zhu Q. Anesthesiologists' acquisition of hepatitis B virus infection: Risk and prevention. Medicine (Baltimore) 2019;98:e16416. [PMID: 31335690 DOI: 10.1097/MD.0000000000016416] [Reference Citation Analysis]
214 Li R, Li Z, Feng Y, Yang H, Shi Q, Tao Z, Cheng J, Lu X. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis. Apoptosis 2020;25:105-19. [DOI: 10.1007/s10495-019-01583-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
215 Wang F, Sun W, Xiao Q, Liang C, Jiang S, Lian Y, Shao J, Tan S, Zheng S. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2021;100:e24075. [PMID: 33592861 DOI: 10.1097/MD.0000000000024075] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
216 Wang H, Chen XZ, Chen XL, Zhang WH, Liu K, Wang YJ, Tang HR, Hu JK; SIGES research group. Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES). Cancer Med 2021;10:3741-55. [PMID: 33934530 DOI: 10.1002/cam4.3901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Guo X, Cui R, Zhao J, Mo R, Peng L, Yan M. Corosolic acid protects hepatocytes against ethanol-induced damage by modulating mitogen-activated protein kinases and activating autophagy. Eur J Pharmacol. 2016;791:578-588. [PMID: 27663281 DOI: 10.1016/j.ejphar.2016.09.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
218 Wang F, Tang L, Liang B, Jin C, Gao L, Li Y, Li Z, Shao J, Zhang Z, Tan S, Zhang F, Zheng S. Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro. Front Pharmacol 2021;12:658811. [PMID: 33967802 DOI: 10.3389/fphar.2021.658811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ming L, Qiao X, Yi L, Siren D, He J, Hai L, Guo F, Xiao Y, Ji R. Camel milk modulates ethanol-induced changes in the gut microbiome and transcriptome in a mouse model of acute alcoholic liver disease. J Dairy Sci 2020;103:3937-49. [PMID: 32171514 DOI: 10.3168/jds.2019-17247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
220 Zhao L, Li X, Cheng Y, Chen R, Shao J, Zhou Y, Li Q, Liao H, Zhao Y, Liu L, Su H, Liu Y, Liu Y, Xu D. Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation. Antiviral Res. 2018;154:26-34. [PMID: 29630974 DOI: 10.1016/j.antiviral.2018.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
221 Yang R, Guan MJ, Zhao N, Li MJ, Zeng T. Roles of extrahepatic lipolysis and the disturbance of hepatic fatty acid metabolism in TNF-α -induced hepatic steatosis. Toxicology 2019;411:172-80. [PMID: 30359672 DOI: 10.1016/j.tox.2018.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
222 Wang H, Li X, Dong G, Yan F, Zhang J, Shi H, Ning Z, Gao M, Cheng D, Ma Q, Wang C, Zhao M, Dai J, Li C, Li Z, Zhang H, Xiong H. Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell. Inflammation 2021;44:671-81. [PMID: 33083887 DOI: 10.1007/s10753-020-01366-y] [Reference Citation Analysis]
223 Xu XL, Jiang LS, Wu CS, Pan LY, Lou ZQ, Peng CT, Dong Y, Ruan B. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? J Formos Med Assoc 2021:S0929-6646(21)00344-2. [PMID: 34325952 DOI: 10.1016/j.jfma.2021.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
224 Xianyu J, Feng J, Yang Y, Tang J, Xie G, Fan L. Correlation of oxidative stress in patients with HBV-induced liver disease with HBV genotypes and drug resistance mutations. Clin Biochem. 2018;55:21-27. [PMID: 29596793 DOI: 10.1016/j.clinbiochem.2018.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
225 Khamphaya T, Chukijrungroat N, Saengsirisuwan V, Mitchell-Richards KA, Robert ME, Mennone A, Ananthanarayanan M, Nathanson MH, Weerachayaphorn J. Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor. Hepatology 2018;67:560-74. [PMID: 29023819 DOI: 10.1002/hep.29588] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
226 Wang S, Gao S, Zhou D, Qian X, Luan J, Lv X. The role of the CD39-CD73-adenosine pathway in liver disease. J Cell Physiol 2021;236:851-62. [PMID: 32648591 DOI: 10.1002/jcp.29932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
227 Sun M, Cui H, Liang M, Wang W, Wang Y, Liu X, Liu S, Cao L. Perceived dietary salt intake and the risk of primary liver cancer: a population-based prospective study. J Hum Nutr Diet 2020;33:833-40. [PMID: 32548912 DOI: 10.1111/jhn.12761] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Luo M, Sun H, Jiang Q, Chai Y, Li C, Yang B, Hong Z. Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma. Front Oncol 2021;11:777356. [PMID: 34926286 DOI: 10.3389/fonc.2021.777356] [Reference Citation Analysis]
229 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
230 Ou G, Liu X, Jiang Y. HLA-DPB1 alleles in hepatitis B vaccine response: A meta-analysis. Medicine (Baltimore) 2021;100:e24904. [PMID: 33832070 DOI: 10.1097/MD.0000000000024904] [Reference Citation Analysis]
231 Yu C, Song C, Lv J, Zhu M, Yu C, Guo Y, Yang L, Chen Y, Chen Z, Jiang T, Ma H, Jin G, Shen H, Hu Z, Li L; China Kadoorie Biobank Collaborative Group. Prediction and clinical utility of a liver cancer risk model in Chinese adults: A prospective cohort study of 0.5 million people. Int J Cancer 2021;148:2924-34. [PMID: 33521941 DOI: 10.1002/ijc.33487] [Reference Citation Analysis]
232 Yang G, Mahadik B, Mollot T, Pinsky J, Jones A, Robinson A, Najafali D, Rivkin D, Katsnelson J, Piard C, Fisher JP. Engineered Liver Tissue Culture in an In Vitro Tubular Perfusion System. Tissue Eng Part A 2020;26:1369-77. [PMID: 33054685 DOI: 10.1089/ten.TEA.2020.0213] [Reference Citation Analysis]
233 Wang J, Liu R, Zhao Y, Ma Z, Sang Z, Wen Z, Yang X, Xie H. Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Front Oncol 2021;11:743055. [PMID: 34513717 DOI: 10.3389/fonc.2021.743055] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
234 Yang M, Song XQ, Han M, Liu H. The role of Resolvin D1 in liver diseases. Prostaglandins Other Lipid Mediat 2022;160:106634. [PMID: 35292355 DOI: 10.1016/j.prostaglandins.2022.106634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
235 Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Glob Health. 2017;5:e624-e632. [PMID: 28495266 DOI: 10.1016/s2214-109x(17)30142-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 13.3] [Reference Citation Analysis]
236 Shen J, Li C, Yan L, Li B, Xu M, Yang J, Wang W, Wen T. Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy. Ann Hepatol 2018;17:134-43. [PMID: 29311397 DOI: 10.5604/01.3001.0010.7545] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
237 Dong C, Peng S. Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China. Hepatology 2016;63:347-8. [PMID: 25953408 DOI: 10.1002/hep.27882] [Reference Citation Analysis]
238 Lin Q, Wang DG, Zhang ZQ, Liu DP. Applications of Virus Vector-Mediated Gene Therapy in China. Hum Gene Ther 2018;29:98-109. [PMID: 29284296 DOI: 10.1089/hum.2017.238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
239 Shuai C, Xia GQ, Yuan F, Wang S, Lv XW. CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease. Eur J Pharmacol 2021;905:174198. [PMID: 34033815 DOI: 10.1016/j.ejphar.2021.174198] [Reference Citation Analysis]
240 Xie H, Tian S, Cui L, Yan J, Bai Y, Li X, Wang M, Zhang F, Duan F. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma. Cancer Manag Res 2019;11:4065-73. [PMID: 31118814 DOI: 10.2147/CMAR.S195485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
241 Dai Z, Wong IOL, Xie C, Xu W, Xiang Y, Peng L, Lau EHY. Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China. Clin Microbiol Infect 2021:S1198-743X(21)00344-X. [PMID: 34197929 DOI: 10.1016/j.cmi.2021.06.024] [Reference Citation Analysis]
242 Yang Y, Zhou YB, Xiao PL, Shi Y, Chen Y, Liang S, Yihuo WL, Song XX, Jiang QW. Prevalence of and risk factors associated with Cryptosporidium infection in an underdeveloped rural community of southwest China. Infect Dis Poverty 2017;6:2. [PMID: 28126012 DOI: 10.1186/s40249-016-0223-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
243 Chen YY, Li H, Xu BY, Zheng X, Li BL, Wang XB, Huang Y, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Li H, Wang SY, Zhang YH, Meng ZJ; Chinese Chronic Liver Failure (CLIF) Consortium. Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study. Front Med (Lausanne) 2021;8:779744. [PMID: 34869500 DOI: 10.3389/fmed.2021.779744] [Reference Citation Analysis]
244 Gao Y, Li J, Wang J, Li X, Li J, Chu S, Li L, Chen N, Zhang L. Ginsenoside Rg1 prevent and treat inflammatory diseases: A review. International Immunopharmacology 2020;87:106805. [DOI: 10.1016/j.intimp.2020.106805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
245 Cao QY, Zou ZM, Wang Q, He CN, Zou Q, Wang B. MRI manifestations of hepatic perfusion disorders. Exp Ther Med 2018;15:5199-204. [PMID: 29805544 DOI: 10.3892/etm.2018.6090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Zeng QL, Yu ZJ, Shang J, Xu GH, Sun CY, Liu N, Li CX, Lv J, Liu YM, Liang HX, Li ZQ, Pan YJ, Hu QY, Li W, Zhang DW, Wang FS. Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels. Open Forum Infect Dis 2020;7:ofaa208. [PMID: 32626791 DOI: 10.1093/ofid/ofaa208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
247 Elkhoely A. Diallyl sulfide ameliorates carbon tetrachloride-induced hepatotoxicity in rats via suppressing stress-activated MAPK signaling pathways. J Biochem Mol Toxicol 2019;33:e22307. [PMID: 30811752 DOI: 10.1002/jbt.22307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
248 Liu C, Wu W, Shang H, Lin S, Xun Z, Huang E, Lin J, Yang B, Ou Q. Prediction value of serum HBV large surface protein in different phases of HBV infection and virological response of chronic hepatitis B patients. Clin Chim Acta 2018;481:12-9. [PMID: 29453971 DOI: 10.1016/j.cca.2018.02.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
249 Yan JY, Li ZQ, Yu ZJ, Kan QC. Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels. J Cell Biochem 2019;120:6632-41. [PMID: 30368885 DOI: 10.1002/jcb.27959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
250 Xu XP, Peng XQ, Yin XM, Liu Y, Shi ZY. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation. Acta Histochem 2020;122:151576. [PMID: 32778238 DOI: 10.1016/j.acthis.2020.151576] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
251 Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ 2019;97:230-8. [PMID: 30992636 DOI: 10.2471/BLT.18.219469] [Cited by in Crossref: 57] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
252 Pang Y, Lv J, Kartsonaki C, Yu C, Guo Y, Du H, Bennett D, Bian Z, Chen Y, Yang L, Turnbull I, Wang H, Li H, Holmes MV, Chen J, Chen Z, Li L. Association of physical activity with risk of hepatobiliary diseases in China: a prospective cohort study of 0.5 million people. Br J Sports Med 2021;55:1024-33. [PMID: 32826226 DOI: 10.1136/bjsports-2020-102174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
253 Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, Bragg F, Yang L, Bian Z, Millwood IY, Hao J, Han X, Zang Y, Chen J, Li L, Holmes MV, Chen Z. Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People. Hepatology 2018;68:1308-18. [PMID: 29734463 DOI: 10.1002/hep.30083] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 19.0] [Reference Citation Analysis]
254 Xu XL, Lu KJ, Zhu ML, Du YL, Zhu YF, Zhang NN, Wang XJ, Kang XQ, Xu DM, Ying XY, Yu RS, Lu CY, Ji JS, You J, Du YZ. Sialic Acid-Functionalized pH-Triggered Micelles for Enhanced Tumor Tissue Accumulation and Active Cellular Internalization of Orthotopic Hepatocarcinoma. ACS Appl Mater Interfaces. 2018;10:31903-31914. [PMID: 30178997 DOI: 10.1021/acsami.8b09498] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
255 Yang X, He F, Zhang Y, Xue J, Li K, Zhang X, Zhu L, Wang Z, Wang H, Yang S. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-M ψ Axis and Modulating Gut Microbiota in Mice. Alcohol Clin Exp Re 2019;43:411-24. [DOI: 10.1111/acer.13950] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
256 Wu W, Yan H, Zhao H, Sun W, Yang Q, Sheng J, Shi Y. Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: Differentiate it from No-ACLF. Liver Int. 2018;38:248-257. [PMID: 28646630 DOI: 10.1111/liv.13504] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
257 Long L, Yang Y, Zhu T, Zhang X, Qi S, Liu T, Song K, Wang D, Gao H. New pentacyclic triterpenoids isolated from Leptopus chinensis and their hepatoprotective activities on tert-butyl hydroperoxide-induced oxidative injury. RSC Adv 2021;11:12784-93. [PMID: 35423795 DOI: 10.1039/d1ra00962a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Fang W, Zhao S, Zhang Y, Ma Y, Zhao H, Zhang L. Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China. Oncologist 2019;24:S11-20. [PMID: 30819827 DOI: 10.1634/theoncologist.2019-IO-S1-s03] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Diao Y, Hu D, Hu X, Wang P, Wang X, Luo X, Wang H, Ning Q. The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase. Infect Dis Ther. [DOI: 10.1007/s40121-022-00629-5] [Reference Citation Analysis]
260 Duan F, Bai YH, Cui L, Li XH, Yan JY, Wang MQ. Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(1): 92-100 [PMID: 31966917 DOI: 10.4251/wjgo.v12.i1.92] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
261 Zhou GP, Jiang YZ, Sun LY, Zhu ZJ. Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Res Ther 2020;11:419. [PMID: 32977828 DOI: 10.1186/s13287-020-01935-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
262 Shen J, Dai J, Zhang Y, Xie F, Yu Y, Li C, Wen T. Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: A multicentre study. J Viral Hepat 2021;28:1587-96. [PMID: 34464991 DOI: 10.1111/jvh.13606] [Reference Citation Analysis]
263 Bai C, Wang Z, Guan J, Jin K, Sun J, Ding Y, Ji X, Meng R. Probable factors affecting clinical outcomes of internal jugular vein stenosis. Ann Transl Med 2019;7:621. [PMID: 31930022 DOI: 10.21037/atm.2019.11.05] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
264 Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis 2019;23:39-50. [PMID: 30454831 DOI: 10.1016/j.cld.2018.09.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
265 Liu Y, Wang X, Xiao J, Sun J, Zhang Y. Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma. J Int Med Res 2020;48:300060520908763. [PMID: 32290747 DOI: 10.1177/0300060520908763] [Reference Citation Analysis]
266 Xu L, Hu C, Hu H, Dai X, Gao H, Guo Y, Huang Y, Yang Z, Tao R, Zhu B, Xu Y. Importance of fibrosis 4 index score and mode of anti-fungal treatment to the outcome of Cryptococcal meningitis in hepatitis B virus-infected patients. Infect Dis (Lond) 2019;51:113-21. [PMID: 30676149 DOI: 10.1080/23744235.2018.1523553] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
267 Chan KH, Bennett DA, Kurmi OP, Yang L, Chen Y, Lv J, Guo Y, Bian Z, Yu C, Chen X, Dong C, Li L, Chen Z, Lam KBH; China Kadoorie Biobank Study Group. Solid fuels for cooking and tobacco use and risk of major chronic liver disease mortality: a prospective cohort study of 0.5 million Chinese adults. Int J Epidemiol 2020;49:45-55. [PMID: 31650183 DOI: 10.1093/ije/dyz216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
268 Dong Z, Chen Y, Yang C, Zhang M, Chen A, Yang J, Huang Y. STAT gene family mRNA expression and prognostic value in hepatocellular carcinoma. Onco Targets Ther 2019;12:7175-91. [PMID: 31564902 DOI: 10.2147/OTT.S202122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
269 Valery PC, Bernardes CM, Stuart KA, Hartel GF, McPhail SM, Skoien R, Rahman T, Clark PJ, Horsfall LU, Hayward KL, Gupta R, Powell EE. Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC). Patient Prefer Adherence 2020;14:599-611. [PMID: 32256051 DOI: 10.2147/PPA.S236818] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
270 Jiang B, Chen Y, Zhou K, Zheng Y, Chen Y, Li Q, Zhu C, Xia F, Gu T, Guo Y, Lu Y. Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults. Obesity (Silver Spring) 2019;27:707-15. [PMID: 30942551 DOI: 10.1002/oby.22432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
271 Han SW, Wang XJ, Cui BS, Sun H, Chen H, Ferreira D, Li S, Hamann MT. Hepatoprotective Glucosyloxybenzyl 2-Hydroxy-2-isobutylsuccinates from Pleione yunnanensis. J Nat Prod 2021;84:738-49. [PMID: 33606538 DOI: 10.1021/acs.jnatprod.0c01117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 He Y, Xu R, Peng L, Hu X. Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis. PLoS One 2021;16:e0254829. [PMID: 34324544 DOI: 10.1371/journal.pone.0254829] [Reference Citation Analysis]
273 Wu F, Zhang FY, Tan GQ, Chen WJ, Huang B, Yan L, Zhang HL, Chen S, Jiao Y, Wang BL. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway. BMC Cancer 2021;21:704. [PMID: 34130659 DOI: 10.1186/s12885-021-08327-0] [Reference Citation Analysis]
274 Wang ZX, Peng W, Zhang XY, Wen TF, Li C. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy. Medicine (Baltimore) 2021;100:e24476. [PMID: 33725934 DOI: 10.1097/MD.0000000000024476] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Li B, Feng F, Jia H, Jiang Q, Cao S, Wei L, Zhang Y, Lu J. Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis. Food Funct 2021;12:2404-17. [PMID: 33570057 DOI: 10.1039/d0fo02270e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
276 Liu Y, Ren J, Wu Z, Shen L, Shan H, Dai X, Li J, Qiu Y, Ren W, Yao J, Li L. The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China. Hum Vaccin Immunother 2021;17:1530-5. [PMID: 33315518 DOI: 10.1080/21645515.2020.1814096] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
277 Liu Z, Yang Q, Shi O, Ye W, Chen X, Zhang T. The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study. J Viral Hepat 2018;25:1543-54. [PMID: 29851287 DOI: 10.1111/jvh.12938] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
278 Zhao Z, Chen L, Zhao Y, Wang C, Duan C, Yang G, Niu C, Li S. Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.Appl Microbiol Biotechnol. 2020;104:5273-5282. [PMID: 32335723 DOI: 10.1007/s00253-020-10633-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
279 Zhang R, Huang W, Li G, Hu Y. Noninvasive Strategy Based on Real-Time in Vivo Cataluminescence Monitoring for Clinical Breath Analysis. Anal Chem 2017;89:3353-61. [DOI: 10.1021/acs.analchem.6b03898] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
280 Liu XL, Pan Q, Zhang RN, Shen F, Yan SY, Sun C, Xu ZJ, Chen YW, Fan JG. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. World J Gastroenterol 2016; 22(44): 9844-9852 [PMID: 27956809 DOI: 10.3748/wjg.v22.i44.9844] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
281 Lim S, Oh TJ, Koh KK. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Int J Cardiol 2015;201:408-14. [PMID: 26310987 DOI: 10.1016/j.ijcard.2015.08.107] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
282 Chen Q, Liu J, He Y, Yang L, Luo H, Wang Y, Zhang X, Li N. Prevalence of HBsAg among reproductive age couples in Chongqing: A population-based, cross-sectional study. PLoS One 2021;16:e0260028. [PMID: 34780552 DOI: 10.1371/journal.pone.0260028] [Reference Citation Analysis]
283 Jin Y, Geng N, Zhao L, Li Y, Zheng L, Zhu W, Sheng Q, An Z, Wang J, Dou X, Bai H. The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China. Viral Immunol 2020;33:99-104. [PMID: 31834847 DOI: 10.1089/vim.2019.0104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
284 Zhou Q, Li X, Wang Q, Shen H, Zhang Y, Zhang S, Acharya G. Hepatitis B Virus Infection in Preconception Period Among Women of Reproductive Age in Rural China - A Nationwide Study. Paediatr Perinat Epidemiol 2017. [PMID: 28617973 DOI: 10.1111/ppe.12371] [Reference Citation Analysis]
285 Li X, Kang N, Qi X, Huang Y. Artificial intelligence in the diagnosis of cirrhosis and portal hypertension. J Med Ultrason (2001) 2021. [PMID: 34787742 DOI: 10.1007/s10396-021-01153-8] [Reference Citation Analysis]
286 Yao J, Zhang X, Li J, Zhao D, Gao B, Zhou H, Gao S, Zhang L. Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3. Cancer Cell Int 2018;18:208. [PMID: 30564064 DOI: 10.1186/s12935-018-0704-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
287 Huang J, Xue W, Wang M, Wu Y, Singh M, Zhu Y, Kumar R, Lin S. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Diabetes Metab Syndr Obes 2021;14:3417-25. [PMID: 34349535 DOI: 10.2147/DMSO.S316096] [Reference Citation Analysis]
288 Xiao Y, Ni L, Cui Z, Sun L, Zhou X, Chen X, Li L, Tang C, Yin F, Du J, Liu L, Lu G, Cui X, Quan Y. Discrepant results of hepatitis B virus genotype determination by PCR and DNA sequencing. Journal of Virological Methods 2022. [DOI: 10.1016/j.jviromet.2022.114503] [Reference Citation Analysis]
289 Chen L, Shi J, Lu Z, Ye Y, Zhou X, Tan Y. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase. Clin Res Hepatol Gastroenterol 2019;43:310-6. [PMID: 30528063 DOI: 10.1016/j.clinre.2018.10.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Wu S, Luo W, Wu Y, Chen H, Peng J. HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases. BMC Gastroenterol. 2020;20:121. [PMID: 32316928 DOI: 10.1186/s12876-020-01263-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
291 Hu S, Liu X, Gao Y, Zhou R, Wei M, Dong J, Yan H, Zhao Y. Hepatitis B Virus Inhibits Neutrophil Extracellular Trap Release by Modulating Reactive Oxygen Species Production and Autophagy. J I 2019;202:805-15. [DOI: 10.4049/jimmunol.1800871] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
292 Zeng QL, Xu GH, Zhang JY, Li W, Zhang DW, Li ZQ, Liang HX, Li CX, Yu ZJ. Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study. J Hepatol 2017;66:1123-9. [PMID: 28189754 DOI: 10.1016/j.jhep.2017.01.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
293 Lu SC, Zhong JH, Tan JT, Tang HL, Liu XG, Xiang BD, Li LQ, Peng T. Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis. BMJ Open 2015;5:e008263. [PMID: 26438136 DOI: 10.1136/bmjopen-2015-008263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
294 Zheng H, Zhang G, Wang F, Yin Z, Miao N, Sun X, Liang X, Cui F. Self-motivated medical care-seeking behaviors and disease progression in a community-based cohort of chronic hepatitis B virus-infected patients in China. BMC Public Health 2019;19:901. [PMID: 31286924 DOI: 10.1186/s12889-019-7061-1] [Reference Citation Analysis]
295 Shoaib M, Naz A, Osra FA, Abro SH, Qazi SU, Siddiqui FA, Shah MR, Mirza AZ. Green synthesis and characterization of silver-entecavir nanoparticles with stability determination. Arabian Journal of Chemistry 2021;14:102974. [DOI: 10.1016/j.arabjc.2020.102974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
296 Wang Y, Wang S, Che Y, Chen D, Liu Y, Shi Y. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics. Medicine (Baltimore) 2021;100:e26917. [PMID: 34414947 DOI: 10.1097/MD.0000000000026917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Wu X, Roberto JB, Knupp A, Kenerson HL, Truong CD, Yuen SY, Brempelis KJ, Tuefferd M, Chen A, Horton H, Yeung RS, Crispe IN. Precision-cut human liver slice cultures as an immunological platform. J Immunol Methods 2018;455:71-9. [PMID: 29408707 DOI: 10.1016/j.jim.2018.01.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
298 Xu G, Lv X, Feng Y, Li H, Chen C, Lin H, Li H, Wang C, Chen J, Sun J. Study on the effect of active components of Schisandra chinensis on liver injury and its mechanisms in mice based on network pharmacology. Eur J Pharmacol 2021;910:174442. [PMID: 34492285 DOI: 10.1016/j.ejphar.2021.174442] [Reference Citation Analysis]
299 Fanning GC, Zoulim F, Hou J, Bertoletti A. Therapeutic strategies for hepatitis B virus infection: towards a cure. Nat Rev Drug Discov. 2019;18:827-844. [PMID: 31455905 DOI: 10.1038/s41573-019-0037-0] [Cited by in Crossref: 118] [Cited by in F6Publishing: 130] [Article Influence: 39.3] [Reference Citation Analysis]
300 Xu D, Du M, Zhang J, Xiong P, Li W, Zhang H, Xiong W, Liu F, Liu J. DNMT1 mediated promoter methylation of GNAO1 in hepatoma carcinoma cells. Gene 2018;665:67-73. [DOI: 10.1016/j.gene.2018.04.080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
301 Chen C, Zhang SY, Zhang DD, Li XY, Zhang YL, Li WX, Yan JJ, Wang M, Xun JN, Lu C, Ling Y, Huang YX, Chen L. Clinical features of acute hepatitis E super-infections on chronic hepatitis B. World J Gastroenterol 2016; 22(47): 10388-10397 [PMID: 28058019 DOI: 10.3748/wjg.v22.i47.10388] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
302 Su S, Wong WC, Ong JJ, Seto W, Zhang L. The optimal screening strategy for chronic hepatitis B virus infection in China – Authors' reply. The Lancet Global Health 2022;10:e793. [DOI: 10.1016/s2214-109x(22)00165-6] [Reference Citation Analysis]
303 Chen XF, Fan YN, Si CW, Yu YY, Shang J, Yu ZJ, Mao Q, Xie Q, Zhao W, Li J, Gao ZL, Wu SM, Tang H, Cheng J, Chen XY, Zhang WH, Wang H, Xu ZN, Wang L, Dai J, Xu JH. Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks. World J Clin Cases 2021; 9(18): 4690-4699 [PMID: 34222435 DOI: 10.12998/wjcc.v9.i18.4690] [Reference Citation Analysis]
304 Nguyen CB, Houchen CW, Ali N. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases. Exp Biol Med (Maywood) 2017;242:242-9. [PMID: 27694285 DOI: 10.1177/1535370216672746] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
305 Wang L, Zhu M, Cao L, Yao M, Lu Y, Wen X, Zhang Y, Ning J, Long H, Zhu Y, Hu G, Dang S, Fu Q, Chen L, Zhang X, Zhao J, Gao Z, Nan Y, Lu F. Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study. J Clin Transl Hepatol 2019;7:313-21. [PMID: 31915600 DOI: 10.14218/JCTH.2019.00040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
306 Hu G, Zhai S, Yu S, Huang Z, Gao R. Circular RNA circRHOBTB3 is downregulated in hepatocellular carcinoma and suppresses cell proliferation by inhibiting miR-18a maturation. Infect Agent Cancer 2021;16:48. [PMID: 34187598 DOI: 10.1186/s13027-021-00384-1] [Reference Citation Analysis]
307 Zhou D, Fan JG. Microbial metabolites in non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(17): 2019-2028 [PMID: 31114130 DOI: 10.3748/wjg.v25.i17.2019] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
308 Liu H, Yao Y, Wang Y, Ma L, Liu X, Guo S, Feng X, Chen Y, Chen X, Liu Z, Ji L, Li D, Zhou Y. Ideal cardiovascular health metrics and the risk of non-alcoholic fatty liver disease: A cross-sectional study in northern China. Liver Int 2019;39:950-5. [PMID: 30712318 DOI: 10.1111/liv.14060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
309 El-Atem N, Irvine KM, Valery PC, Wojcik K, Horsfall L, Johnson T, Janda M, McPhail SM, Powell EE. Identifying areas of need relative to liver disease: geographic clustering within a health service district. Aust Health Rev 2017;41:407-18. [PMID: 27509003 DOI: 10.1071/AH15225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
310 Liu J, Wang X, Wang Q, Qiao Y, Jin X, Li Z, Du M, Yan W, Jing W, Liu M, Wang A. Hepatitis B virus infection among 90 million pregnant women in 2853 Chinese counties, 2015-2020: a national observational study. Lancet Reg Health West Pac 2021;16:100267. [PMID: 34590067 DOI: 10.1016/j.lanwpc.2021.100267] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
311 Zhang Y, Li L. State of the art—Artificial liver in China. Artif Organs 2019;43:336-41. [DOI: 10.1111/aor.13448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
312 Li X, Wang Y, Yang H, Dai Y. Liver and Hepatocyte Transplantation: What Can Pigs Contribute? Front Immunol 2021;12:802692. [PMID: 35095885 DOI: 10.3389/fimmu.2021.802692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Gao D, Song J, Chen C, Zhu S, Wang Z, Sun S. Relationships of hepatitis B virus infection with clinicopathological features in breast cancer and survival outcomes in central China. Transl Cancer Res 2020;9:2511-7. [PMID: 35117610 DOI: 10.21037/tcr.2020.03.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Liu J, Zhang S, Liu M, Wang Q, Shen H, Zhang Y. Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: A population-based cross-sectional study. J Viral Hepat 2018;25:401-11. [PMID: 29193618 DOI: 10.1111/jvh.12829] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
315 Bai C, Ding J, Da Z, Sun J, Liu C, Pan L, Ya J, Wang Z, Guan J, Jin K, Ding Y, Ji X, Ding J, Meng R. Probable risk factors of internal jugular vein stenosis in Chinese patients-A real-world cohort study. Clin Neurol Neurosurg 2020;191:105678. [PMID: 31955125 DOI: 10.1016/j.clineuro.2020.105678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
316 Shen J, Liu J, Li C, Wen T, Yan L, Yang J. The prognostic significance of serum HBeAg on the recurrence and long-term survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. J Viral Hepat 2018;25:1057-65. [PMID: 29660216 DOI: 10.1111/jvh.12911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
317 Yu Y, Cai J, She Z, Li H. Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. Adv Sci (Weinh) 2019;6:1801585. [PMID: 30828530 DOI: 10.1002/advs.201801585] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 17.7] [Reference Citation Analysis]
318 Sun XY, Dong JH, Qin KE, Lan LG, Li HB, Huang Y, Cao S, Li ZJ, Dai LJ. Single-center study on transplantation of livers donated after cardiac death: A report of 6 cases. Exp Ther Med 2016;11:988-92. [PMID: 26998025 DOI: 10.3892/etm.2016.3001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
319 Wang L, Xu M, Jones OD, Li Z, Liang Y, Yu Q, Li J, Wu Y, Lei X, He B, Yue H, Xiao L, Zhou R, Zhang W, Zhou X, Zhang Y, Bryant JL, Ma J, Liu Y, Xu X. Nonalcoholic fatty liver disease experiences accumulation of hepatic liquid crystal associated with increasing lipophagy. Cell Biosci 2020;10:55. [PMID: 32280452 DOI: 10.1186/s13578-020-00414-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Ou G, Liu X, Xu H, Ji X, Liu X, Wang J. Variation and expression of HLA-DPB1 gene in HBV infection. Immunogenetics 2021;73:253-61. [PMID: 33710355 DOI: 10.1007/s00251-021-01213-w] [Reference Citation Analysis]
321 Yang B, Wang C, Xie H, Wang Y, Huang J, Rong Y, Zhang H, Kong H, Yang Y, Lu Y. MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents. Cell Death Dis 2019;10:784. [PMID: 31611551 DOI: 10.1038/s41419-019-2023-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
322 Zhou J, Yang W, Zhang S, He X, Lin J, Zhou T, Li Y, Wang G, Chen J. Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma. Cancer Manag Res 2019;11:7159-69. [PMID: 31534368 DOI: 10.2147/CMAR.S217170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
323 Pang Y, Kartsonaki C, Guo Y, Chen Y, Yang L, Bian Z, Bragg F, Millwood IY, Yu C, Lv J, Chen J, Li L, Holmes MV, Chen Z. Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people. Int J Cancer 2019;145:1245-53. [PMID: 30665257 DOI: 10.1002/ijc.32148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
324 Chen GF, Wei L, Chen J, Duan ZP, Dou XG, Xie Q, Zhang WH, Lu LG, Fan JG, Cheng J. Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data. PLoS One. 2016;11:e0155934. [PMID: 27276081 DOI: 10.1371/journal.pone.0155934] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
325 Du F, Sun H, Sun F, Yang S, Tan H, Li X, Chai Y, Jiang Q, Han D. Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs. Front Pharmacol 2022;13:924523. [DOI: 10.3389/fphar.2022.924523] [Reference Citation Analysis]
326 Wang A, Li M, Huang H, Xiao Z, Shen J, Zhao Y, Yin J, Kaboli PJ, Cao J, Cho CH, Wang Y, Li J, Wu X. A review of Penthorum chinense Pursh for hepatoprotection: Traditional use, phytochemistry, pharmacology, toxicology and clinical trials. Journal of Ethnopharmacology 2020;251:112569. [DOI: 10.1016/j.jep.2020.112569] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
327 Gu D, Yi H, Jiang K, Fakhar SH, Shi J, He Y, Liu B, Guo Y, Fan X, Li S. Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease. Life Sci 2021;267:118986. [PMID: 33385408 DOI: 10.1016/j.lfs.2020.118986] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 Shen J, He L, Li C, Wen T, Chen W, Lu C, Yan L, Li B, Yang J. Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics. Oncotarget 2016;7:80783-93. [PMID: 27811374 DOI: 10.18632/oncotarget.13038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
329 Hou J, Ning Q, Duan Z, Chen Y, Xie Q, Wang FS, Zhang L, Wu S, Tang H, Li J, Lin F, Yang Y, Gong G, Flaherty JF, Gaggar A, Mo S, Cheng C, Camus G, Chen C, Huang Y, Jia J, Zhang M; GS-US-320-0110 and GS-US-320-0108 China Investigators. 3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China. J Clin Transl Hepatol 2021;9:324-34. [PMID: 34221918 DOI: 10.14218/JCTH.2020.00145] [Reference Citation Analysis]
330 Zhao X, Shi X, Lv M, Yuan B, Wu J. Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing. Hum Vaccin Immunother 2021;17:1818-24. [PMID: 33606606 DOI: 10.1080/21645515.2020.1847951] [Reference Citation Analysis]
331 Hu DS, Zhu SH, Li X, Chen QF, Lin CJ, Fang DH, Wu JS. Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic Individuals. Can J Gastroenterol Hepatol 2019;2019:8748459. [PMID: 31929982 DOI: 10.1155/2019/8748459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
332 Feng F, Jiang Q, Cao S, Cao Y, Li R, Shen L, Zhu H, Wang T, Sun L, Liang E, Sun H, Chai Y, Li X, Liu G, Yang R, Yang Z, Yang Y, Xin S, Li BA. Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma. Biochim Biophys Acta Gen Subj 2018;1862:1017-30. [PMID: 29369785 DOI: 10.1016/j.bbagen.2018.01.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
333 Estrada-Martínez LE, Moreno-Celis U, Cervantes-Jiménez R, Ferriz-Martínez RA, Blanco-Labra A, García-Gasca T. Plant Lectins as Medical Tools against Digestive System Cancers. Int J Mol Sci 2017;18:E1403. [PMID: 28671623 DOI: 10.3390/ijms18071403] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
334 Yan X, Qiu Y. Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma. Cancer Lett 2016;379:220-4. [PMID: 26282785 DOI: 10.1016/j.canlet.2015.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
335 Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu X, Xia C, Yang Z, Li H, Wei W, Chen W, He J. Liver cancer incidence and mortality in China: Temporal trends and projections to 2030. Chin J Cancer Res. 2018;30:571-579. [PMID: 30700925 DOI: 10.21147/j.issn.1000-9604.2018.06.01] [Cited by in Crossref: 62] [Cited by in F6Publishing: 80] [Article Influence: 15.5] [Reference Citation Analysis]
336 Guan J, Wang G, Yang Q, Chen C, Deng J, Gu X, Zhu H. Natural Killer T Cells in Various Mouse Models of Hepatitis. Biomed Res Int 2021;2021:1782765. [PMID: 33506011 DOI: 10.1155/2021/1782765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
337 Zhao J, Wang ZY, Li J, Yu HW, Meng QH. Influence of diabetes mellitus on energy metabolism in patients with alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:110-5. [PMID: 31567641 DOI: 10.1097/MEG.0000000000001560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
338 Yin F, Feng F, Wang L, Wang X, Li Z, Cao Y. SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity. Cell Death Dis 2019;10:672. [PMID: 31511501 DOI: 10.1038/s41419-019-1884-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
339 Guo XY, Sun F, Chen JN, Wang YQ, Pan Q, Fan JG. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World J Gastroenterol 2018; 24(3): 323-337 [PMID: 29391755 DOI: 10.3748/wjg.v24.i3.323] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
340 Fan R, Yin X, Liu Z, Liu Z, Lau G, Hou J. A hepatitis B-free generation in China: from dream to reality. Lancet Infect Dis 2016;16:1103-5. [PMID: 27676339 DOI: 10.1016/S1473-3099(16)30327-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
341 Zhao Y, Chen YL, Song HQ, Huang PY, Wang LY, Liu W, Huang BK, Lv FP, Huang C, Yan B, Li XJ. Effects of maternal hepatitis B surface antigen positive status on the pregnancy outcomes: A retrospective study in Xiamen, China, 2011-2018. PLoS One 2020;15:e0229732. [PMID: 32155166 DOI: 10.1371/journal.pone.0229732] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
342 Liu R, Zhao D, Zhang X, Han S, Yang Y, Ma J, Meng D. A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation. Oncotarget 2017;8:93103-16. [PMID: 29190981 DOI: 10.18632/oncotarget.21860] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
343 Yang L, Wei C, Li Y, He X, He M. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers. Biomark Med 2020;14:1485-500. [PMID: 33155836 DOI: 10.2217/bmm-2020-0099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
344 Liu K. Hepatitis B infection in China: the stigma behind the stigmata. Liver Int 2016;36:1582-4. [DOI: 10.1111/liv.13189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
345 Sun Y, Song Y, Liu C, Geng J. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling. Biochem Biophys Res Commun 2019;516:584-90. [PMID: 31239155 DOI: 10.1016/j.bbrc.2019.06.104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
346 Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, Chen ZM, Cui GL, Li W, Zhang DW, Li J, Lv J, Li ZQ, Liang HX, Sun CY, Pan YJ, Liu YM, Wang FS. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study. Clin Infect Dis 2021:ciaa1939. [PMID: 33395488 DOI: 10.1093/cid/ciaa1939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
347 Fei-Fei S, Xiao-Dan R, Hai-Qiang L, He-Wei Z. Value of anti-hepatitis B virus in serum tested by enzyme linked immunosorbent assay 3 in diagnosis of hepatitis B: A protocol for systemic review and meta analysis. Medicine (Baltimore) 2021;100:e23961. [PMID: 33545977 DOI: 10.1097/MD.0000000000023961] [Reference Citation Analysis]
348 Tan ZB, Fan HJ, Wu YT, Xie LP, Bi YM, Xu HL, Chen HM, Li J, Liu B, Zhou YC. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling. J Ethnopharmacol 2019;232:62-72. [PMID: 30553869 DOI: 10.1016/j.jep.2018.12.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
349 Wu Q, Li D, Sun T, Liu J, Ou H, Zheng L, Hou X, Li W, Fan F. Bai-He-Gu-Jin-Tang formula suppresses lung cancer via AKT/GSK3β/β-catenin and induces autophagy via the AMPK/mTORC1/ULK1 signaling pathway. J Cancer 2021;12:6576-87. [PMID: 34659548 DOI: 10.7150/jca.62779] [Reference Citation Analysis]
350 Geng M, Wang L, Zhang Y, Pei W, Qi M, Yang M, Xu J, Liang Y, Lü K, He C, Gao J. [Lysosomal membrane protein Sidt2 deletion impairs autophagy in human hepatocytes]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1207-13. [PMID: 34549712 DOI: 10.12122/j.issn.1673-4254.2021.08.12] [Reference Citation Analysis]
351 Dong J, Ying J, Qiu X, Lu Y, Zhang M. Advanced Strategies for Eliminating the cccDNA of HBV. Dig Dis Sci 2018;63:7-15. [PMID: 29159681 DOI: 10.1007/s10620-017-4842-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
352 Bria A, Marda J, Zhou J, Sun X, Cao Q, Petersen BE, Pi L. Hepatic progenitor cell activation in liver repair. Liver Res 2017;1:81-7. [PMID: 29276644 DOI: 10.1016/j.livres.2017.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
353 Wang Y, Li XY, Wu LL, Zheng XY, Deng Y, Li MJ, You X, Chong YT, Hao YT. Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data. Eur J Gastroenterol Hepatol 2020;32:120-6. [PMID: 31688313 DOI: 10.1097/MEG.0000000000001592] [Reference Citation Analysis]
354 Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322 [DOI: 10.3748/wjg.v27.i48.8302] [Reference Citation Analysis]
355 Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T. Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis. Virol J 2016;13:172. [PMID: 27756381 DOI: 10.1186/s12985-016-0635-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
356 Huang Y, Huang X, Zeng J, Lin J. Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells. Front Oncol 2021;11:667669. [PMID: 34150633 DOI: 10.3389/fonc.2021.667669] [Reference Citation Analysis]
357 Koneru M, Sahu BD, Mir SM, Ravuri HG, Kuncha M, Mahesh Kumar J, Kilari EK, Sistla R. Capsaicin, the pungent principle of peppers, ameliorates alcohol-induced acute liver injury in mice via modulation of matrix metalloproteinases. Can J Physiol Pharmacol 2018;96:419-27. [DOI: 10.1139/cjpp-2017-0473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
358 Wang L, Wang W, Yao X, Rong W, Wu F, Chen B, Liu M, Lin S, Liu Y, Wu J. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion. Oncotarget. 2017;8:79971-79981. [PMID: 29108379 DOI: 10.18632/oncotarget.20402] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
359 Fu K, Zhou H, Wang C, Gong L, Ma C, Zhang Y, Li Y. A review: Pharmacology and pharmacokinetics of Schisandrin A. Phytotherapy Research. [DOI: 10.1002/ptr.7456] [Reference Citation Analysis]
360 Gong T, Ning X, Deng Z, Liu M, Zhou B, Chen X, Huang S, Xu Y, Chen Z, Luo R. Propofol‐induced miR‐219‐5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3‐mediated Wnt/β‐catenin signalling activation. J Cell Biochem 2019;120:16934-45. [DOI: 10.1002/jcb.28952] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
361 Shen J, Tang L, Zhang X, Peng W, Wen T, Li C, Yang J, Liu G. A Novel Index in Hepatocellular Carcinoma Patients After Curative Hepatectomy: Albumin to Gamma-Glutamyltransferase Ratio (AGR). Front Oncol 2019;9:817. [PMID: 31612101 DOI: 10.3389/fonc.2019.00817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
362 Lei Q, Zhang Y, Ke C, Yan C, Huang P, Shen H, Lei H, Chen Y, Luo J, Meng Z. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma. Exp Ther Med. 2018;15:3074-3079. [PMID: 29456711 DOI: 10.3892/etm.2018.5748] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
363 张从玉, 鄢金柱, 张志娟, 左维泽. 聚乙二醇干扰素α-2a联合胸腺肽α1治疗慢性乙型肝炎疗效的系统评价. 世界华人消化杂志 2017; 25(20): 1869-1876 [DOI: 10.11569/wcjd.v25.i20.1869] [Reference Citation Analysis]
364 Long G, Shen J, Zhou L. A-G Score Associated With Outcomes in Solitary Hepatocellular Carcinoma Patients After Hepatectomy. Front Oncol 2020;10:1286. [PMID: 32850396 DOI: 10.3389/fonc.2020.01286] [Reference Citation Analysis]
365 Xing X, Yuan H, Liu H, Tan X, Zhao B, Wang Y, Ouyang J, Lin M, Liu X, Huang A. Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00041-3. [PMID: 33662630 DOI: 10.1016/j.gpb.2020.09.005] [Reference Citation Analysis]
366 Wei S, Yin P, Newman IM, Qian L, Shell DF, Yuen LW. Comparison of Patterns of Use of Unrecorded and Recorded Spirits: Survey of Adult Drinkers in Rural Central China. Int J Environ Res Public Health 2017;14:E1099. [PMID: 28937617 DOI: 10.3390/ijerph14101099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
367 Ning Q, Liu YF, Ye PJ, Gao P, Li ZP, Tang SY, He DX, Tang SS, Wei H, Yu CY. Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma. ACS Appl Mater Interfaces 2019;11:10578-88. [PMID: 30802029 DOI: 10.1021/acsami.9b00634] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
368 Gao L, Hu Y, Shi X, Li X, Zhang D, Ren H. 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients. Ann Hepatol 2020;19:329-34. [PMID: 31884016 DOI: 10.1016/j.aohep.2019.10.006] [Reference Citation Analysis]
369 Liu J, Yao N, Zhao Y. Improvement of telbivudine on renal function and massive proteinuria: A case report. J Viral Hepat 2017;24 Suppl 1:75-7. [PMID: 29082647 DOI: 10.1111/jvh.12789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
370 Zhang J, Lu Y, Yang X, Zhao Y. Supplementation of okra seed oil ameliorates ethanol-induced liver injury and modulates gut microbiota dysbiosis in mice. Food Funct 2019;10:6385-98. [DOI: 10.1039/c9fo00189a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
371 Qi X, Guo X, Fan D. Difference in Budd-Chiari syndrome between the West and China. Hepatology 2015;62:656. [PMID: 25476543 DOI: 10.1002/hep.27628] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
372 Ahmad J, Wahab R, Siddiqui MA, Farshori NN, Saquib Q, Ahmad N, Al-khedhairy AA. Neodymium oxide nanostructures and their cytotoxic evaluation in human cancer cells. Journal of Trace Elements in Medicine and Biology 2022;73:127029. [DOI: 10.1016/j.jtemb.2022.127029] [Reference Citation Analysis]
373 Shi YM, Li YY, Lin JY, Zheng L, Zhu YM, Huang J. The discovery of a novel eight-mRNA-lncRNA signature predicting survival of hepatocellular carcinoma patients. J Cell Biochem 2018. [PMID: 30485492 DOI: 10.1002/jcb.28028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
374 He X, Sun H, Jiang Q, Chai Y, Li X, Wang Z, Zhu B, You S, Li B, Hao J, Xin S. Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4. Front Oncol 2021;11:735447. [PMID: 34381736 DOI: 10.3389/fonc.2021.735447] [Reference Citation Analysis]
375 Shu B, Zhou YX, Li H, Zhang RZ, He C, Yang X. The METTL3/MALAT1/PTBP1/USP8/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis. Cell Death Discov 2021;7:368. [PMID: 34839365 DOI: 10.1038/s41420-021-00756-x] [Reference Citation Analysis]
376 Ding WJ, Wang MM, Wang GS, Shen F, Qin JJ, Fan JG. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects. J Gastroenterol Hepatol. 2015;30:1753-1758. [PMID: 25974331 DOI: 10.1111/jgh.12998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
377 Jiang G, Sun C, Wang X, Mei J, Li C, Zhan H, Liao Y, Zhu Y, Mao J. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification. Bioengineered 2022;13:5216-35. [PMID: 35170400 DOI: 10.1080/21655979.2022.2037374] [Reference Citation Analysis]
378 Yue X, Ge C, Zhuge S, He H, Yang H, Xu H, Huang A, Zhao Y. Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: A hospital-based study. J Viral Hepat 2018;25:373-80. [PMID: 29091317 DOI: 10.1111/jvh.12818] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
379 Gao Y, Chu S, Zhang Z, Chen N. Hepataprotective effects of ginsenoside Rg1 - A review. J Ethnopharmacol 2017;206:178-83. [PMID: 28427912 DOI: 10.1016/j.jep.2017.04.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
380 Arslan F, Franci G, Maria Nastri B, Pagliano P. Hepatitis B virus-induced hepatocarcinogenesis: A virological and oncological perspective. J Viral Hepat 2021;28:1104-9. [PMID: 34003561 DOI: 10.1111/jvh.13551] [Reference Citation Analysis]
381 Tan J, Tang X, He Y, Xu X, Qiu D, Chen J, Zhang Q, Zhang L. In-patient Expenditure Between 2012 and 2020 Concerning Patients With Liver Cirrhosis in Chongqing: A Hospital-Based Multicenter Retrospective Study. Front Public Health 2022;10:780704. [PMID: 35350474 DOI: 10.3389/fpubh.2022.780704] [Reference Citation Analysis]
382 Simões e Silva AC, Miranda AS, Rocha NP, Teixeira AL. Renin angiotensin system in liver diseases: Friend or foe? World J Gastroenterol 2017; 23(19): 3396-3406 [PMID: 28596676 DOI: 10.3748/wjg.v23.i19.3396] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 37] [Article Influence: 9.2] [Reference Citation Analysis]
383 Qu J, Feng P, Luo Y, Lü X. Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases. Medicine (Baltimore) 2016;95:e4270. [PMID: 27472699 DOI: 10.1097/MD.0000000000004270] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
384 Zhao Y, Mao YF, Tang YS, Ni MZ, Liu QH, Wang Y, Feng Q, Peng JH, Hu YY. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings. World J Gastroenterol 2018; 24(30): 3448-3461 [PMID: 30122883 DOI: 10.3748/wjg.v24.i30.3448] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
385 Sun P, Zhang G, Su X, Jin C, Yu B, Yu X, Lv Z, Ma H, Zhang M, Wei W, Li W. Maintenance of Primary Hepatocyte Functions In Vitro by Inhibiting Mechanical Tension-Induced YAP Activation. Cell Rep 2019;29:3212-3222.e4. [PMID: 31801084 DOI: 10.1016/j.celrep.2019.10.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
386 Kim MS, Ong M, Qu X. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? World J Gastroenterol 2016; 22(1): 8-23 [PMID: 26755857 DOI: 10.3748/wjg.v22.i1.8] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
387 Zhang H, Yang L, Wang Y, Huang W, Li Y, Chen S, Song G, Ren L. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease. Life Sci 2020;257:118090. [PMID: 32679144 DOI: 10.1016/j.lfs.2020.118090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
388 Meng F, Zhao J, Tan AT, Hu W, Wang SY, Jin J, Wu J, Li Y, Shi L, Fu JL, Yu S, Shen Y, Liu L, Luan J, Shi M, Xie Y, Zhou CB, Wong RW, Lu-En W, Koh S, Bertoletti A, Wang T, Zhang JY, Wang FS. Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial. Hepatol Int 2021;15:1402-12. [PMID: 34850325 DOI: 10.1007/s12072-021-10250-2] [Reference Citation Analysis]
389 Chen T, Wang J, Qiu H, Yu Q, Yan T, Qi C, Cao F, Tian Z, Guo D, Yao N, Yang Y, He Y, Zhao Y, Liu J. Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China. Medicine (Baltimore) 2018;97:e11406. [PMID: 29979437 DOI: 10.1097/MD.0000000000011406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
390 Nurmamat M, Yan H, Wang R, Zhao H, Li Y, Wang X, Nurmaimaiti K, Kurmanjiang T, Luo D, Baodi J, Xu G, Li J. Novel Copper(II) Complex with a 4-Acylpyrazolone Derivative and Coligand Induce Apoptosis in Liver Cancer Cells. ACS Med Chem Lett 2021;12:467-76. [PMID: 33738074 DOI: 10.1021/acsmedchemlett.0c00680] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
391 Fan CX, Li XF, Zhan YF, Zheng QY, Feng Q, Shi XY, Li YJ, Tan HB. Efficacy and safety of interferon α-2b as an add-on therapy to long-term oral nucleotide analogue therapy in hepatitis B e antigen-negative patients. Shijie Huaren Xiaohua Zazhi 2017; 25(11): 983-988 [DOI: 10.11569/wcjd.v25.i11.983] [Reference Citation Analysis]
392 Lenci I, Milana M, Grassi G, Manzia TM, Gazia C, Tisone G, Angelico R, Baiocchi L. Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? World J Gastroenterol 2020; 26(18): 2166-2176 [PMID: 32476783 DOI: 10.3748/wjg.v26.i18.2166] [Cited by in CrossRef: 2] [Article Influence: 1.0] [Reference Citation Analysis]
393 Wu H, Chen G, Wang J, Deng M, Yuan F, Gong J. TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway. Cell Prolif. 2020;53:e12731. [PMID: 31755616 DOI: 10.1111/cpr.12731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
394 Sun Y, Chang J, Liu X, Liu C. Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis. BMJ Open 2019;9:e029793. [PMID: 31712333 DOI: 10.1136/bmjopen-2019-029793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
395 Su X, Zheng L, Zhang H, Shen T, Liu Y, Hu X. Secular Trends of Acute Viral Hepatitis Incidence and Mortality in China, 1990 to 2019 and Its Prediction to 2030: The Global Burden of Disease Study 2019. Front Med 2022;9:842088. [DOI: 10.3389/fmed.2022.842088] [Reference Citation Analysis]
396 Yang C, Yang S, Feng C, Zhang C, Xu W, Zhang L, Yan Y, Deng J, Ohore OE, Li J. Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study. PLoS One 2018;13:e0192396. [PMID: 29415050 DOI: 10.1371/journal.pone.0192396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
397 Xiao FF, Wang YZ, Dong F, Li XL, Zhang T. Congenital hepatic fibrosis in a young boy with congenital hypothyroidism: A case report. World J Clin Cases 2021; 9(6): 1475-1482 [PMID: 33644218 DOI: 10.12998/wjcc.v9.i6.1475] [Reference Citation Analysis]
398 Zhou Y, Lv X, Qu H, Zhao K, Fu L, Zhu L, Ye G, Guo J. Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation. Gene 2018;677:317-23. [PMID: 30118889 DOI: 10.1016/j.gene.2018.08.052] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
399 Hu N, Liu J, Xue X, Li Y. The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. Eur J Pharmacol 2020;882:173269. [PMID: 32553811 DOI: 10.1016/j.ejphar.2020.173269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
400 Chen H, Chen L. Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China. PLoS One. 2017;12:e0175189. [PMID: 28380022 DOI: 10.1371/journal.pone.0175189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
401 Xiao Y, Chen B, Yang K, Wang Q, Liu P, Gu Y, Zhong Q, Liu Z, He Y, Liu Q. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma. Exp Cell Res 2019;383:111542. [PMID: 31381879 DOI: 10.1016/j.yexcr.2019.111542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 Li Q, Li HJ, Xu T, Du H, Huan Gang CL, Fan G, Zhang Y. Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases. Front Pharmacol 2018;9:29. [PMID: 29441019 DOI: 10.3389/fphar.2018.00029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
403 Sun Y, Zhai W, Liu X, Song X, Gao X, Xu K, Tang B. Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma. J Nanobiotechnology 2020;18:60. [PMID: 32299505 DOI: 10.1186/s12951-020-00617-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
404 Zhang HB, Su W, Xu H, Zhang XY, Guan YF. HSD17B13: A Potential Therapeutic Target for NAFLD. Front Mol Biosci 2021;8:824776. [PMID: 35071330 DOI: 10.3389/fmolb.2021.824776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
405 Fan JG, Wang FS. Reply: To PMID 19399912. Hepatology 2015;62:657. [PMID: 25476406 DOI: 10.1002/hep.27627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
406 Li J, Fan JG. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease. J Clin Transl Hepatol 2020;8:13-7. [PMID: 32274341 DOI: 10.14218/JCTH.2020.00019] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 47.0] [Reference Citation Analysis]
407 Shan QL, Chen NN, Meng GZ, Qu F. Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p. Cancer Manag Res 2020;12:4715-24. [PMID: 32606962 DOI: 10.2147/CMAR.S249582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
408 Abdel-Megeed RM, Hamed AR, Matloub AA, Kadry MO, Abdel-Hamid AZ. Regulation of apoptotic and inflammatory signaling pathways in hepatocellular carcinoma via Caesalpinia gilliesii galactomannan. Mol Cell Biochem 2019;451:173-84. [PMID: 30030776 DOI: 10.1007/s11010-018-3404-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
409 Guan W, Gao Z, Huang C, Fang M, Feng H, Chen S, Wang M, Zhou J, Hong S, Gao C. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma. Glycoconj J 2020;37:231-40. [DOI: 10.1007/s10719-019-09906-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
410 Lin ZX, Ruan DY, Jia CC, Wang TT, Cheng JT, Huang HQ, Wu XY. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy. Clin Transl Oncol 2020;22:370-80. [PMID: 31201606 DOI: 10.1007/s12094-019-02137-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
411 Pang Y, Kartsonaki C, Turnbull I, Guo Y, Chen Y, Clarke R, Bian Z, Bragg F, Millwood IY, Yang L, Huang Y, Yang Y, Zhang X, Chen J, Li L, Holmes MV, Chen Z. Adiposity in relation to risks of fatty liver, cirrhosis and liver cancer: a prospective study of 0.5 million Chinese adults. Sci Rep 2019;9:785. [PMID: 30692555 DOI: 10.1038/s41598-018-36460-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
412 Shi M, Dong B, Yang W, Su S, Zhang H. Preventive and therapeutic role of Tanshinone ⅡA in hepatology. Biomedicine & Pharmacotherapy 2019;112:108676. [DOI: 10.1016/j.biopha.2019.108676] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
413 Zhang C, Li J, Cheng Y, Meng F, Song JW, Fan X, Fan H, Li J, Fu YL, Zhou MJ, Hu W, Wang SY, Fu YJ, Zhang JY, Xu RN, Shi M, Hu X, Zhang Z, Ren X, Wang FS. Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients. Gut 2022:gutjnl-2021-325915. [PMID: 35361683 DOI: 10.1136/gutjnl-2021-325915] [Reference Citation Analysis]
414 Zhou Y, Lv X, Qu H, Zhao K, Fu L, Zhu L, Ye G, Guo J. Differential expression of circular RNAs in hepatic tissue in a model of liver fibrosis and functional analysis of their target genes. Hepatol Res 2018;49:324-34. [DOI: 10.1111/hepr.13284] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
415 Xu Z, Li H, Wen F, Bai C, Chen P, Fan F, Hu N, Stowasser S, Kang J. Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis. Adv Ther 2019;36:621-31. [PMID: 30729456 DOI: 10.1007/s12325-019-0887-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
416 Zheng Y, Xu K, Hu H, Draz MS, Wu W, Li L. Prevalence and Incidence of Non-alcohol Fatty Liver Disease in Chronic Hepatitis B Population in Southeast China: A Community-Based Study. Front Med (Lausanne) 2021;8:683872. [PMID: 34350196 DOI: 10.3389/fmed.2021.683872] [Reference Citation Analysis]
417 Yang YT, Huang AL, Zhao Y. The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study. Vaccine 2019;37:458-63. [PMID: 30527659 DOI: 10.1016/j.vaccine.2018.11.067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
418 Yao Z, Li J, Guan Z, Ye Y, Chen Y. Liver disease screening based on densely connected deep neural networks. Neural Netw 2020;123:299-304. [PMID: 31891840 DOI: 10.1016/j.neunet.2019.11.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
419 Qiao JT, Cui C, Qing L, Wang LS, He TY, Yan F, Liu FQ, Shen YH, Hou XG, Chen L. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. Metabolism 2018;81:13-24. [PMID: 29106945 DOI: 10.1016/j.metabol.2017.09.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 12.4] [Reference Citation Analysis]
420 Qiu Y, Wu ZK, Wu J, Yao J, Liu Y, Ren W, Sun YJ, Shen LZ, Ren JJ. Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children. Hum Vaccin Immunother 2022;:1-6. [PMID: 35507912 DOI: 10.1080/21645515.2022.2061247] [Reference Citation Analysis]
421 Wang X, Bai Y, Yan X, Li J, Lin B, Dai L, Xu C, Li H, Li D, Yang T, Zhang T. Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway. Anticancer Drugs 2021;32:548-57. [PMID: 33675610 DOI: 10.1097/CAD.0000000000001062] [Reference Citation Analysis]
422 Ping Y, Song M, Wang M, Li Z, Zhang Y. CDR3 repertoire diversity of CD8+ T lymphocytes in patients with HCV. Cell Immunol 2019;336:34-9. [PMID: 30591202 DOI: 10.1016/j.cellimm.2018.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
423 Roesch-dietlen F, González-santes M, Sánchez-maza Y, Díaz-roesch F, Cano-contreras A, Amieva-balmori M, García-zermeño K, Salgado-vergara L, Remes-troche J, Ortigoza-gutiérrez S. Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liver. Revista de Gastroenterología de México (English Edition) 2021;86:28-35. [DOI: 10.1016/j.rgmxen.2020.01.004] [Reference Citation Analysis]
424 Jiang H, Guan Q, Xiao Y, Feng Z, Yu G, Pan Q. Strontium Alleviates Endoplasmic Reticulum Stress in a Nonalcoholic Fatty Liver Disease Model. J Med Food 2018. [PMID: 30457429 DOI: 10.1089/jmf.2018.4186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
425 Liu K, Mccaughan GW. Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. In: Yu J, editor. Obesity, Fatty Liver and Liver Cancer. Singapore: Springer; 2018. pp. 3-18. [DOI: 10.1007/978-981-10-8684-7_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
426 Zhu XB, Zhuo LY, Yue M, Liu M, Zang F, Fan HZ, Wu JJ, Xia XS, Zhang AM, Yu RB, Huang P. Genetic variants in IFIH1 and DDX58 influence hepatitis C virus clearance in Chinese Han population. J Med Virol 2019;91:1097-103. [PMID: 30633820 DOI: 10.1002/jmv.25398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
427 Khan H, Ullah H, Nabavi SM. Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects. Food Chem Toxicol 2019;124:182-91. [PMID: 30529260 DOI: 10.1016/j.fct.2018.12.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 8.8] [Reference Citation Analysis]
428 Wu T, Wu N, Ma YX, Wu J, Gao Y, Pan XB. Role of hepatitis B antibody in predicting reactivation of resolved hepatitis B virus infection in leukemia patients. Antiviral Res 2020;177:104765. [PMID: 32171856 DOI: 10.1016/j.antiviral.2020.104765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
429 Wang J, Li WT, Zheng YX, Zhao SS, Li N, Huang Y, Zhou RR, Huang ZB, Fan XG. The Association between Helicobacter pylori Infection and Chronic Hepatitis C: A Meta-Analysis and Trial Sequential Analysis. Gastroenterol Res Pract 2016;2016:8780695. [PMID: 26904112 DOI: 10.1155/2016/8780695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
430 Ma M, Duan R, Zhong H, Liang T, Guo L. The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD. J Immunol Res 2019;2019:3954890. [PMID: 30719457 DOI: 10.1155/2019/3954890] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
431 Feng D. The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Liver Research 2020;4:23-7. [DOI: 10.1016/j.livres.2020.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
432 Zhou DK, Qian XH, Cheng J, Chen LH, Wang WL. Clinical significance of down-regulated HINT2 in hepatocellular carcinoma. Medicine (Baltimore) 2019;98:e17815. [PMID: 31770197 DOI: 10.1097/MD.0000000000017815] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
433 Aguilar-Guadarrama AB, Rios MY. Flavonoids, Sterols and Lignans from Cochlospermum vitifolium and Their Relationship with Its Liver Activity. Molecules 2018;23:E1952. [PMID: 30081608 DOI: 10.3390/molecules23081952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
434 Obmann VC, Marx C, Hrycyk J, Berzigotti A, Ebner L, Mertineit N, Gräni C, Heverhagen JT, Christe A, Huber AT. Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR). Abdom Radiol (NY) 2021;46:1912-21. [PMID: 33156949 DOI: 10.1007/s00261-020-02834-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
435 Liu ZN, Wu X, Fang Q, Li ZX, Xia GQ, Cai JN, Lv XW. CD73 Attenuates Alcohol-Induced Liver Injury and Inflammation via Blocking TLR4/MyD88/NF-κB Signaling Pathway. J Inflamm Res 2022;15:53-70. [PMID: 35023943 DOI: 10.2147/JIR.S341680] [Reference Citation Analysis]
436 Sun LY, Zhang H, Li ZL, Li C, Wang MD, Yang T. How to predict global trends in HCC mortality if neglecting more than half the world's cases? J Hepatol 2017;67:887-8. [PMID: 28627362 DOI: 10.1016/j.jhep.2017.05.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
437 Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release 2020;327:641-66. [PMID: 32911014 DOI: 10.1016/j.jconrel.2020.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
438 Xiao Z, Zhou F, Zhou B, Yang J. [Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-α in patients with chronic hepatitis B]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:150-5. [PMID: 30890501 DOI: 10.12122/j.issn.1673-4254.2019.09.04] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
439 Cai M, Hao Y, Zhong J, Yao W, Cao X, Gu G, Qin G. Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study. Can J Gastroenterol Hepatol 2019;2019:9046260. [PMID: 31380321 DOI: 10.1155/2019/9046260] [Reference Citation Analysis]
440 Ji D, Chen GF, Niu XX, Zhang M, Wang C, Shao Q, Wu V, Wang Y, Cheng G, Hurwitz SJ, Schinazi RF, Lau G. Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study. Metabol Open 2021;10:100090. [PMID: 33889834 DOI: 10.1016/j.metop.2021.100090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
441 Yuan J, Yin WY, Wang Y, Chen J, Zhang ZM, Tang YX, Pei SY, Tan LX, Hu XW, Fan XG, Li N. Cargo-laden erythrocyte ghosts target liver mediated by macrophages. Transfus Apher Sci 2021;60:102930. [PMID: 32933846 DOI: 10.1016/j.transci.2020.102930] [Reference Citation Analysis]
442 Feng YQ, Li BA, Feng F, Chen YS, Ren YX, Zhang H, Cao S. Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents. Onco Targets Ther 2020;13:7165-76. [PMID: 32801748 DOI: 10.2147/OTT.S244474] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
443 Yu L, Liu X, Wang X, Yan F, Wang P, Jiang Y, Du J, Yang Z. TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma. Oncoimmunology 2021;10:1942673. [PMID: 34249476 DOI: 10.1080/2162402X.2021.1942673] [Reference Citation Analysis]
444 Li K, Tharwat M, Larson EL, Felgendreff P, Hosseiniasl SM, Rmilah AA, Safwat K, Ross JJ, Nyberg SL. Re-Endothelialization of Decellularized Liver Scaffolds: A Step for Bioengineered Liver Transplantation. Front Bioeng Biotechnol 2022;10:833163. [DOI: 10.3389/fbioe.2022.833163] [Reference Citation Analysis]
445 Zhou F, Zhou J, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis. Hepatology 2019;70:1119-33. [PMID: 31070259 DOI: 10.1002/hep.30702] [Cited by in Crossref: 162] [Cited by in F6Publishing: 133] [Article Influence: 54.0] [Reference Citation Analysis]
446 Zhou D, Chen YW, Zhao ZH, Yang RX, Xin FZ, Liu XL, Pan Q, Zhou H, Fan JG. Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. Exp Mol Med. 2018;50:1-12. [PMID: 30510243 DOI: 10.1038/s12276-018-0183-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
447 Lin M, Zhang F, Wang Y, Zhang B, Zhang W, Zou X, Zhang M, Zhuge Y. Liver cirrhosis caused by chronic Budd-Chiari syndrome. Medicine (Baltimore) 2017;96:e7425. [PMID: 28834866 DOI: 10.1097/MD.0000000000007425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
448 Xu S, Zhu W, Wan Y, Wang J, Chen X, Pi L, Lobo MK, Ren B, Ying Z, Morris M, Cao Q. Decreased Taurine and Creatine in the Thalamus May Relate to Behavioral Impairments in Ethanol-Fed Mice: A Pilot Study of Proton Magnetic Resonance Spectroscopy. Mol Imaging 2018;17:1536012117749051. [PMID: 29318932 DOI: 10.1177/1536012117749051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
449 Han H, Deng H, Han T, Zhao H, Hou F, Qi X. Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study. Med Sci Monit 2017;23:3324-34. [PMID: 28689209 DOI: 10.12659/msm.902440] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
450 Zhang C, Wang LL, Cao CY, Li N, Talukder M, Li JL. Selenium mitigates cadmium-induced crosstalk between autophagy and endoplasmic reticulum stress via regulating calcium homeostasis in avian leghorn male hepatoma (LMH) cells. Environ Pollut 2020;265:114613. [PMID: 32504893 DOI: 10.1016/j.envpol.2020.114613] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
451 Lai K, Zhang C, Ke W, Gao Y, Zhou S, Liu L, Yang Y. Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China. Clin Drug Investig 2017;37:233-47. [PMID: 27928739 DOI: 10.1007/s40261-016-0486-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
452 Hu Q, Liao W, Zhang Z, Shi S, Hou S, Ji N, Zhang X, Zhang Q, Liao Y, Li L, Zhu Z, Chen Y, Chen J, Yu F, Yang Q, Xiao H, Fu C, Du H, Wang Q, Cao H, Xiao H, Li R. The hepatoprotective effects of plant-based foods based on the "gut-liver axis": a prospective review. Crit Rev Food Sci Nutr 2022;:1-27. [PMID: 35466839 DOI: 10.1080/10408398.2022.2064423] [Reference Citation Analysis]
453 Chen J, Tang D, Li H, Zhang P. Expression changes of serum LINC00941 and LINC00514 in HBV infection-related liver diseases and their potential application values. J Clin Lab Anal 2021;:e24143. [PMID: 34825738 DOI: 10.1002/jcla.24143] [Reference Citation Analysis]
454 Zhou Y, Wu M, Xu L, Cheng J, Shen J, Yang T, Zhang L. Bmal1 Regulates Macrophage Polarize Through Glycolytic Pathway in Alcoholic Liver Disease. Front Pharmacol 2021;12:640521. [PMID: 33790796 DOI: 10.3389/fphar.2021.640521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
455 Wang H, Cao G, Fu J, Lv G. Hepatitis Viruses and Hepatoma. In: Bast RC, Hait WN, Kufe DW, Weichselbaum RR, Holland JF, Croce CM, Piccart-gebart M, Wang H, Hong WK, Pollock RE, editors. Holland-Frei Cancer Medicine. Hoboken: John Wiley & Sons, Inc.; 2016. pp. 1-6. [DOI: 10.1002/9781119000822.hfcm031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
456 Bode AM, Dong Z, Wang H. Cancer prevention and control: alarming challenges in China. Natl Sci Rev. 2016;3:117-127. [PMID: 27308066 DOI: 10.1093/nsr/nwv054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
457 Zhang T, Xu J, Ye L, Lin X, Xu Y, Pan X, Weng X, Ye C, Fan L, Ren Y, Shan PF. Age, Gender and Geographic Differences in Global Health Burden of Cirrhosis and Liver Cancer due to Nonalcoholic Steatohepatitis. J Cancer 2021;12:2855-65. [PMID: 33854586 DOI: 10.7150/jca.52282] [Reference Citation Analysis]
458 Ou G, Xu H, Yu H, Liu X, Yang L, Ji X, Wang J, Liu Z. The roles of HLA-DQB1 gene polymorphisms in hepatitis B virus infection. J Transl Med 2018;16:362. [PMID: 30563535 DOI: 10.1186/s12967-018-1716-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
459 Li C, Su HB, Liu XY, Zhang LN, Hu JH. High-dependency units play a key role in the treatment of a Chinese military patient who developed liver failure while abroad. Mil Med Res 2019;6:29. [PMID: 31522692 DOI: 10.1186/s40779-019-0220-y] [Reference Citation Analysis]
460 Lin Z, Hu B, Ni W, Mao X, Zhou H, Lv J, Yin B, Shen Z, Wu M, Ding W, Xiao M, Ni R. Expression pattern of BCCIP in hepatocellular carcinoma is correlated with poor prognosis and enhanced cell proliferation. Tumour Biol 2016. [PMID: 27832471 DOI: 10.1007/s13277-016-5424-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
461 Wang S, Gao S, Li Y, Qian X, Luan J, Lv X. Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. Front Cell Dev Biol 2021;9:716842. [PMID: 34386499 DOI: 10.3389/fcell.2021.716842] [Reference Citation Analysis]
462 Wang Q, Huang A, Wang JB, Zou Z. Chronic Drug-Induced Liver Injury: Updates and Future Challenges. Front Pharmacol 2021;12:627133. [PMID: 33762948 DOI: 10.3389/fphar.2021.627133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol 2018;84:1467-77. [PMID: 29607530 DOI: 10.1111/bcp.13593] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
464 Lai Z, Chen Z, Zhang A, Niu Z, Cheng M, Huo C, Xu J. The Gut Microbiota in Liver Transplantation Recipients During the Perioperative Period. Front Physiol 2022;13:854017. [PMID: 35530507 DOI: 10.3389/fphys.2022.854017] [Reference Citation Analysis]
465 Al-oqail MM, Farshori NN, Al-sheddi ES, Al-massarani SM, Siddiqui MA, Al-khedhairy AA. Petroselinum sativum protects HepG2 cells from cytotoxicity and oxidative stress induced by hydrogen peroxide. Mol Biol Rep 2020;47:2771-80. [DOI: 10.1007/s11033-020-05380-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
466 Hu T, Sun D, Zhang J, Xue R, Janssen HLA, Tang W, Dong L. Spermine oxidase is upregulated and promotes tumor growth in hepatocellular carcinoma. Hepatol Res 2018;48:967-77. [PMID: 29923661 DOI: 10.1111/hepr.13206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
467 Xu GB, Xiao YH, Zhang QY, Zhou M, Liao SG. Hepatoprotective natural triterpenoids. Eur J Med Chem 2018;145:691-716. [PMID: 29353722 DOI: 10.1016/j.ejmech.2018.01.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
468 Wang JC, Fu R, Tao XW, Mao YF, Wang F, Zhang ZC, Yu WW, Chen J, He J, Sun BC. A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data.Biomark Res. 2020;8:47. [PMID: 32963787 DOI: 10.1186/s40364-020-00219-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
469 You X, Xiao Y, Liu K, Yu Y, Liu Y, Long P, Wang H, Zhou L, Deng Q, Lin Y, Zhang X, He M, Wu T, Yuan Y. Association of plasma antimony concentration with markers of liver function in Chinese adults. Environ Chem 2020;17:304. [DOI: 10.1071/en19195] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
470 Zhao N, Guo FF, Xie KQ, Zeng T. Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease. Cell Mol Life Sci 2018;75:3143-57. [PMID: 29947925 DOI: 10.1007/s00018-018-2852-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
471 Zhai X, Zhu L, Jiang J, Song C, Peng H, Qian J, Zhou M, Zhou Y, Wang Q, Xu J, Wang Z, Liu H, Fan M, Hu Z, Shen H, Zhu F. Virological activity in treatment-naïve HBeAg-negative HBV-infected adult patients: A community-based study in Jiangsu, China. Medicine (Baltimore) 2020;99:e21179. [PMID: 32702877 DOI: 10.1097/MD.0000000000021179] [Reference Citation Analysis]
472 Song Y, Wu X, Yang D, Fang F, Meng L, Liu Y, Cui W. Protective Effect of Andrographolide on Alleviating Chronic Alcoholic Liver Disease in Mice by Inhibiting Nuclear Factor Kappa B and Tumor Necrosis Factor Alpha Activation. Journal of Medicinal Food 2020;23:409-15. [DOI: 10.1089/jmf.2019.4471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
473 Zhang Q, Luo P, Zheng L, Chen J, Zhang J, Tang H, Liu D, He X, Shi Q, Gu L, Li J, Guo Q, Yang C, Wong YK, Xia F, Wang J. 18beta-Glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.06.001] [Reference Citation Analysis]
474 Peng L, Wu YL. Immunotherapy in the Asiatic population: any differences from Caucasian population? J Thorac Dis 2018;10:S1482-93. [PMID: 29951300 DOI: 10.21037/jtd.2018.05.106] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
475 Coppell KJ, Miller JC, Gray AR, Schultz M, Mann JI, Parnell WR. Obesity and the extent of liver damage among adult New Zealanders: findings from a national survey. Obes Sci Pract 2015;1:67-77. [PMID: 27774250 DOI: 10.1002/osp4.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
476 Wu W, Sun S, Wang Y, Zhao R, Ren H, Li Z, Zhao H, Zhang Y, Sheng J, Chen Z, Shi Y. Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure. Front Immunol 2021;12:620365. [PMID: 33717119 DOI: 10.3389/fimmu.2021.620365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
477 Chen Y, Tang D, Wu H, Wu Y, Yuan T, Zhang H, Jiao Y, Yu W, Yan H. Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro. Arch Toxicol 2021;95:2431-42. [PMID: 33852043 DOI: 10.1007/s00204-021-03050-y] [Reference Citation Analysis]
478 Zhang Y, Li D, Jiang Q, Cao S, Sun H, Chai Y, Li X, Ren T, Yang R, Feng F, Li BA, Zhao Q. Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death Dis 2018;9:743. [PMID: 29970890 DOI: 10.1038/s41419-018-0804-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
479 Samra YA, Hamed MF, El-Sheakh AR. Hepatoprotective effect of allicin against acetaminophen-induced liver injury: Role of inflammasome pathway, apoptosis, and liver regeneration. J Biochem Mol Toxicol 2020;34:e22470. [PMID: 32040233 DOI: 10.1002/jbt.22470] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
480 Li LM, Liu H, Liu XH, Hu HB, Liu SM. Clinical significance of exosomal miRNAs and proteins in three human cancers with high mortality in China. Oncol Lett 2019;17:11-22. [PMID: 30655733 DOI: 10.3892/ol.2018.9631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
481 Bi J, Zhang Z, Qin E, Hou J, Liu S, Liu Z, Li S, Wei Z, Zhong Y. Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis. Oncotarget 2017;8:96725-31. [PMID: 29228565 DOI: 10.18632/oncotarget.18075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
482 Yao J, Li S, Zhou L, Luo L, Yuan L, Duan Z, Xu J, Chen Y. Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure. J Clin Apher 2019;34:392-8. [PMID: 30758886 DOI: 10.1002/jca.21690] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
483 Zhuang X, Cui AM, Wang Q, Cheng XY, Shen Y, Cai WH, Li HB, Zhang S, Qin G. Liver Dysfunction during Pregnancy and Its Association of With Preterm Birth in China: A Prospective Cohort Study. EBioMedicine. 2017;26:152-156. [PMID: 29174520 DOI: 10.1016/j.ebiom.2017.11.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
484 Xu QH, Zhu PW, Li B, Shi WQ, Lin Q, Min YL, Ge QM, Yuan Q, Shao Y. Carbohydrate antigen-125, calcium, and hemoglobin as predictive clinical indicator for ocular metastasis in male liver cancer patients. Biosci Rep. 2020;40:BSR20194405. [PMID: 32090248 DOI: 10.1042/bsr20194405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Zhang B, Zhu Z, Li F, Xie X, Ding A. Rapid and sensitive detection of hepatitis B virus by lateral flow recombinase polymerase amplification assay. J Virol Methods 2021;291:114094. [PMID: 33549573 DOI: 10.1016/j.jviromet.2021.114094] [Reference Citation Analysis]
486 Xie QL, Liu Y, Zhu Y. Chromosome region maintenance 1 expression and its association with clinical pathological features in primary carcinoma of the liver. Exp Ther Med 2016;12:59-68. [PMID: 27347018 DOI: 10.3892/etm.2016.3283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
487 Song T, Wang L, Su B, Zeng W, Jiang T, Zhang T, Sun G, Wu H. Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma. J Int Med Res 2020;48:300060519889270. [PMID: 31852373 DOI: 10.1177/0300060519889270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
488 Liu H, Fafeng, Cheng, Tang F, Wang Y, Liu S, Wang X. Paeoniflorin inhibits lipopolysaccharide-induced inflammation in LO2 cells by regulating RhoA/NLRP3 pathway. Journal of Traditional Chinese Medical Sciences 2021;8:161-5. [DOI: 10.1016/j.jtcms.2021.06.001] [Reference Citation Analysis]
489 González IA, Hartley CP, Nalbantoglu I. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft. Am J Clin Pathol 2021;155:435-45. [PMID: 33252121 DOI: 10.1093/ajcp/aqaa147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
490 Cai Z, Zhang J, He Y, Xia L, Dong X, Chen G, Zhou Y, Hu X, Zhong S, Wang Y, Chen H, Xie D, Liu X, Liu J. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma. ESMO Open 2021;6:100021. [PMID: 33508734 DOI: 10.1016/j.esmoop.2020.100021] [Reference Citation Analysis]
491 Wang Y, Takeishi K, Li Z, Cervantes-Alvarez E, Collin de l'Hortet A, Guzman-Lepe J, Cui X, Zhu J. Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks. Organogenesis. 2017;13:83-94. [PMID: 28548903 DOI: 10.1080/15476278.2017.1322243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
492 Valery PC, Powell E, Moses N, Volk ML, McPhail SM, Clark PJ, Martin J. Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease. BMJ Open. 2015;5:e007451. [PMID: 25854973 DOI: 10.1136/bmjopen-2014-007451] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
493 Dong Y, Li X, Yu Y, Lv F, Chen Y. JAK/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B. Life Sci 2020;252:117663. [PMID: 32302624 DOI: 10.1016/j.lfs.2020.117663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
494 Wang L, Cao M, Wei QL, Zhao ZH, Xiang Q, Wang HJ, Zhang HT, Lai GQ. A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. PLoS One 2017;12:e0175992. [PMID: 28426720 DOI: 10.1371/journal.pone.0175992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
495 Hong T, Chen Y, Li X, Lu Y. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxid Med Cell Longev 2021;2021:6889533. [PMID: 34745420 DOI: 10.1155/2021/6889533] [Reference Citation Analysis]
496 Zeng X, Yuan X, Cai Q, Tang C, Gao J. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021;10:1945. [PMID: 34440714 DOI: 10.3390/cells10081945] [Reference Citation Analysis]
497 Hu W, Zhang C, Shi JJ, Zhang JY, Wang FS. Hepatitis C: milestones from discovery to clinical cure. Mil Med Res 2020;7:59. [PMID: 33261650 DOI: 10.1186/s40779-020-00288-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
498 Chen L, Feng J, Xu B, Zhou Y, Zheng X, Wu C, Jiang J. B7-H6 expression in human hepatocellular carcinoma and its clinical significance [corrected]. Cancer Cell Int 2018;18:126. [PMID: 30186042 DOI: 10.1186/s12935-018-0627-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
499 Yang L, Chen Y, Pan W, Wang H, Li N, Tang B. Visualizing the Conversion Process of Alcohol-Induced Fatty Liver to Steatohepatitis in Vivo with a Fluorescent Nanoprobe. Anal Chem 2017;89:6196-201. [DOI: 10.1021/acs.analchem.7b01144] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
500 Liu JY, Lv WJ, Jian JB, Xin XH, Zhao XY, Hu CH. High-resolution three-dimensional visualization of hepatic sinusoids in cirrhotic rats via serial histological sections. Histol Histopathol 2021;36:577-86. [PMID: 33851410 DOI: 10.14670/HH-18-339] [Reference Citation Analysis]
501 Liu J, Jiang J, Mo J, Liu D, Cao D, Wang H, He Y, Wang H. Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma. Hepatology 2019;69:196-208. [PMID: 30070373 DOI: 10.1002/hep.30146] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
502 Liu K, Song S, Fu T, Liu Y, Zhang H, Yan M, He Z, Zhang W, Su H, Li Z, Ji Z, Shao Z. Spatiotemporal Trends in the Incidence of Gastrointestinal Neoplasms in Wuwei City of Northwestern China From 1995 to 2016: A Hospital-Based Retrospective Observational Study. Front Oncol 2021;11:712857. [PMID: 34552871 DOI: 10.3389/fonc.2021.712857] [Reference Citation Analysis]
503 Niu X, Meng Y, Wang Y, Li G. Established Liposome-Coated IMB16-4 Polymeric Nanoparticles (LNPs) for Increasing Cellular Uptake and Anti-Fibrotic Effects In Vitro. Molecules 2022;27:3738. [PMID: 35744862 DOI: 10.3390/molecules27123738] [Reference Citation Analysis]
504 Zhao L, Mehmood A, Soliman MM, Iftikhar A, Iftikhar M, Aboelenin SM, Wang C. Protective Effects of Ellagic Acid Against Alcoholic Liver Disease in Mice. Front Nutr 2021;8:744520. [PMID: 34595202 DOI: 10.3389/fnut.2021.744520] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
505 Yang J, Yang L, Li B, Zhou W, Zhong S, Zhuang Z, Yang B, Chen M, Feng Q. iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine. Biomed Res Int 2016;2016:3290260. [PMID: 28025641 DOI: 10.1155/2016/3290260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
506 Wei XL, Luo HY, Li CF, Jin Y, Zeng ZL, Ju HQ, Wu QN, Wang Y, Mao MJ, Liu WL, Jia WH, Zhang HZ, Li YH, Wang F, Xu RH. Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers. Int J Cancer 2017;141:152-9. [PMID: 28369849 DOI: 10.1002/ijc.30719] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
507 Ndugga N, Lightbourne TG, Javaherian K, Cabezas J, Verma N, Barritt AS 4th, Bataller R. Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA. BMJ Open 2017;7:e013620. [PMID: 28336739 DOI: 10.1136/bmjopen-2016-013620] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
508 Xie H, Yu H, Tian S, Yang X, Wang X, Yang Z, Wang H, Guo Z. What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis. Oncotarget 2017;8:100508-23. [PMID: 29245997 DOI: 10.18632/oncotarget.20119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
509 Yang X, Ma L, Wei R, Ye T, Zhou J, Wen M, Men R, Aqeilan RI, Peng Y, Yang L. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway. Signal Transduct Target Ther 2020;5:75. [PMID: 32499481 DOI: 10.1038/s41392-020-0169-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
510 Cao Z, Xiao H, Li L, Liu M, Lin G, Zhai P, Yong KT, Wang X, Xu G. The Codelivery of siRNA and QDs by pH-Responsive Micelle for Hepatoma Cancer Cells. Front Pharmacol 2019;10:1194. [PMID: 31680969 DOI: 10.3389/fphar.2019.01194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
511 Ye L, Yu Y, Zhao Y. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol 2020;35:482-91. [PMID: 31617598 DOI: 10.1111/jgh.14875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
512 Zhang Y, Tian Z, Ye H, Sun X, Zhang H, Sun Y, Mao Y, Yang Z, Li M. Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity. Cell Death Discov 2022;8:268. [PMID: 35595755 DOI: 10.1038/s41420-022-01062-w] [Reference Citation Analysis]
513 Yan T, He Y, Li Y, Wang J, Chen T, Yang Y, Liu J, Jin L, Zhang Y, Yi R, Zhao Y. With Cytometric Bead Assay, the Interleukin-10/HBV DNA Ratio Is an Early Predictor for Response to Interferon-α Treatment in Chronic Hepatitis B. Journal of Interferon & Cytokine Research 2015;35:779-84. [DOI: 10.1089/jir.2015.0004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
514 Gao X, Chen H, Huang X, Li H, Liu Z, Bo X. ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance. Onco Targets Ther 2019;12:1629-40. [PMID: 30881018 DOI: 10.2147/OTT.S196713] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
515 Irving B, Hutton C, Dennis A, Vikal S, Mavar M, Kelly M, Brady JM. Deep Quantitative Liver Segmentation and Vessel Exclusion to Assist in Liver Assessment. In: Valdés Hernández M, González-castro V, editors. Medical Image Understanding and Analysis. Cham: Springer International Publishing; 2017. pp. 663-73. [DOI: 10.1007/978-3-319-60964-5_58] [Cited by in Crossref: 10] [Article Influence: 2.0] [Reference Citation Analysis]
516 Wu LJ, Chen ZY, Wang Y, Zhao JG, Xie XZ, Chen G. Organoids of liver diseases: From bench to bedside. World J Gastroenterol 2019; 25(16): 1913-1927 [PMID: 31086460 DOI: 10.3748/wjg.v25.i16.1913] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
517 Chen Y, Chen Y, Geng B, Zhang Y, Qin R, Cai Y, Bai F, Yu D. Physical activity and liver health among urban and rural Chinese adults: results from two independent surveys. J Exerc Sci Fit 2021;19:8-12. [PMID: 32904178 DOI: 10.1016/j.jesf.2020.07.004] [Reference Citation Analysis]
518 Devi Daimary U, Girisa S, Parama D, Verma E, Kumar A, Kunnumakkara AB. Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases. J Biochem Mol Toxicol 2021;:e22950. [PMID: 34842329 DOI: 10.1002/jbt.22950] [Reference Citation Analysis]
519 Zhang Y, Hu P, Qi X, Ren H, Mao RC, Zhang JM. A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China. Clin Microbiol Infect. 2016;22:287.e1-287.e9. [PMID: 26548508 DOI: 10.1016/j.cmi.2015.10.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
520 Guo XY, Chen JN, Sun F, Wang YQ, Pan Q, Fan JG. circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. Oxid Med Cell Longev 2017;2017:3960197. [PMID: 29018509 DOI: 10.1155/2017/3960197] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
521 Liu X, Xie X, Ren Y, Shao Z, Zhang N, Li L, Ding X, Zhang L. The role of necroptosis in disease and treatment. MedComm (2020) 2021;2:730-55. [PMID: 34977874 DOI: 10.1002/mco2.108] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 Xie Z, Qiang J, Pi X, Wang J, Chen Y, Yu Q, Zhang Q. Favorable outcome of adjunctive traditional Chinese medicine therapy in liver cirrhosis: A large cohort study in Southwest China. Complementary Therapies in Medicine 2020;51:102446. [DOI: 10.1016/j.ctim.2020.102446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
523 Meng FG, Zhang XN, Liu SX, Wang YR, Zeng T. Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease. Chem Biol Interact 2020;327:109176. [PMID: 32534989 DOI: 10.1016/j.cbi.2020.109176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
524 Yao J, Zhou X, Wang H, Yuan L, Chen Y, Duan Z. Persistently Increased Resting Energy Expenditure Predicts Short-Term Mortality in Patients with Acute-on-Chronic Liver Failure. Ann Nutr Metab 2018;73:2-9. [PMID: 29788014 DOI: 10.1159/000487604] [Reference Citation Analysis]
525 Chen X, Tan XR, Li SJ, Zhang XX. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease. Life Sci 2019;235:116829. [PMID: 31484042 DOI: 10.1016/j.lfs.2019.116829] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
526 Wu HH, Chen YX, Fang SY. Clinicopathological features of isolated pulmonary cryptococcosis in HIV-negative patients. J Int Med Res 2020;48:300060520927877. [PMID: 32527202 DOI: 10.1177/0300060520927877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
527 Fan JG, Wei L, Zhuang H; National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Disease Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). J Dig Dis 2019;20:163-73. [PMID: 30444584 DOI: 10.1111/1751-2980.12685] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
528 Jiang J, Xiong J, Ni J, Chen C, Wang K. Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease. Med Sci Monit 2021;27:e931143. [PMID: 34482357 DOI: 10.12659/MSM.931143] [Reference Citation Analysis]
529 Cao J, Gong J, Tsia Hin Fong CJ, Xiao C, Lin G, Li X, Jie Y, Chong Y. Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection. Biomed Res Int. 2020;2020:6820179. [PMID: 32855968 DOI: 10.1155/2020/6820179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
530 Ke J, Liu F, Liu Y. Glissonean Pedicle Transection with Hepatic Vein Exclusion for Hepatocellular Carcinoma: A Comparative Study with the Pringle Maneuver. Journal of Laparoendoscopic & Advanced Surgical Techniques 2020;30:58-63. [DOI: 10.1089/lap.2019.0484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Lu XJ, Yang XJ, Sun JY, Zhang X, Yuan ZX, Li XH. FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients. Biomark Res 2020;8:48. [PMID: 33005419 DOI: 10.1186/s40364-020-00215-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
532 Yu C, Wang L, Xue H, Lin H, Li Y, Chan S. Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes. Clinics and Research in Hepatology and Gastroenterology 2019;43:58-66. [DOI: 10.1016/j.clinre.2018.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
533 Yang L, Yin K, Zhong Y, Zheng H, Zhao L, Qi L, Peng J. Luminescent Turn-On Upconversion Nanoprobes for Monitoring NADH In Vivo. ACS Appl Nano Mater 2022;5:1095-101. [DOI: 10.1021/acsanm.1c03743] [Reference Citation Analysis]
534 Bahaji Azami NL, Sun M. Zeaxanthin Dipalmitate in the Treatment of Liver Disease. Evid Based Complement Alternat Med 2019;2019:1475163. [PMID: 31531108 DOI: 10.1155/2019/1475163] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
535 Wang F, Zhang L, Wu S, Li W, Sun M, Feng W, Ding D, Yeung-Shan Wong S, Zhu P, Evans GJ, Wing YK, Zhang J, Vlaanderen JJ, Vermeulen RCH, Zhang Y, Chan EY, Li Z, Tse LA. Night shift work and abnormal liver function: is non-alcohol fatty liver a necessary mediator? Occup Environ Med 2019;76:83-9. [PMID: 30514747 DOI: 10.1136/oemed-2018-105273] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
536 Chen L, Cao Z, Yan L, Ding Y, Shen X, Liu K, Xiang X, Xie Q, Zhu C, Bao S, Wang H. Circulating Receptor-Interacting Protein Kinase 3 Are Increased in HBV Patients With Acute-on-Chronic Liver Failure and Are Associated With Clinical Outcome. Front Physiol 2020;11:526. [PMID: 32655398 DOI: 10.3389/fphys.2020.00526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
537 Lin L, Yang S, Xiao Z, Hong P, Sun S, Zhou C, Qian ZJ. The Inhibition Effect of the Seaweed Polyphenol, 7-Phloro-Eckol from Ecklonia Cava on Alcohol-Induced Oxidative Stress in HepG2/CYP2E1 Cells. Mar Drugs 2021;19:158. [PMID: 33802989 DOI: 10.3390/md19030158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Xie H, Tian S, Yu H, Yang X, Liu J, Wang H, Feng F, Guo Z. A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma. Onco Targets Ther 2018;11:3257-65. [PMID: 29910621 DOI: 10.2147/OTT.S165000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
539 Hu Y, Yu H. Prevention strategies of mother-to-child transmission of hepatitis B virus (HBV) infection. Pediatr Investig 2020;4:133-7. [PMID: 32851357 DOI: 10.1002/ped4.12205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
540 Gu S, Lv L, Lin X, Li X, Dai J, Zhang J, Kong R, Xie W, Li J. Using structural analysis to explore the role of hepatitis B virus mutations in immune escape from liver cancer in Chinese, European and American populations. J Biomol Struct Dyn 2020;:1-11. [PMID: 33030111 DOI: 10.1080/07391102.2020.1830852] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
541 Mao D, Xu M, Jiang Q, Sun H, Sun F, Yang R, Chai Y, Li X, Li B, Li Y. A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma. Front Pharmacol 2022;13:951831. [DOI: 10.3389/fphar.2022.951831] [Reference Citation Analysis]
542 Pan XF, He M, Yu C, Lv J, Guo Y, Bian Z, Yang L, Chen Y, Wu T, Chen Z, Pan A, Li L; China Kadoorie Biobank Collaborative Group. Type 2 Diabetes and Risk of Incident Cancer in China: A Prospective Study Among 0.5 Million Chinese Adults. Am J Epidemiol 2018;187:1380-91. [PMID: 29304221 DOI: 10.1093/aje/kwx376] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
543 Peng Y, Yang X, Wang Y. Effect of Paroxetine Combined with Probiotics in Patients with Type 2 Diabetes Mellitus Complicated with Gastrointestinal Dysfunction and Liver Cancer. J Oncol 2021;2021:4529915. [PMID: 34659410 DOI: 10.1155/2021/4529915] [Reference Citation Analysis]
544 Chen Z, Yu W, Zhou Q, Zhang J, Jiang H, Hao D, Wang J, Zhou Z, He C, Xiao Z. A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways. Mol Ther Nucleic Acids 2019;16:707-20. [PMID: 31128422 DOI: 10.1016/j.omtn.2019.04.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
545 El-Dakhly SM, Salama AAA, Hassanin SOM, Yassen NN, Hamza AA, Amin A. Aescin and diosmin each alone or in low dose- combination ameliorate liver damage induced by carbon tetrachloride in rats. BMC Res Notes 2020;13:259. [PMID: 32460808 DOI: 10.1186/s13104-020-05094-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
546 Lin Z, Chen R, Gao B, Qin S, Wu B, Liu J, Cai XC. A highly parallel simulation of patient-specific hepatic flows. Int J Numer Method Biomed Eng 2021;37:e3451. [PMID: 33609008 DOI: 10.1002/cnm.3451] [Reference Citation Analysis]
547 Zhang CT, Liu YF, Huang Q, Liu ZZ, Wang DL, Yang H, Gu HY, Hu R, Zheng ZL, Qiao WJ. Molecular mechanism of chronic HBV infection based on miroRNA regulation. Shijie Huaren Xiaohua Zazhi 2016; 24(8): 1184-1190 [DOI: 10.11569/wcjd.v24.i8.1184] [Reference Citation Analysis]
548 Liu Z, Wu M, Lin D, Li N. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma. J Int Med Res 2020;48:300060520902575. [PMID: 32054358 DOI: 10.1177/0300060520902575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
549 Qian Y, Li L, Ma L, Ji R, Ying S, Zhou J, Fu L, Yang G. Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis. J Clin Lab Anal 2022;:e24296. [PMID: 35218083 DOI: 10.1002/jcla.24296] [Reference Citation Analysis]
550 Shen Y, Wang XL, Wang B, Shao JG, Liu YM, Qin Y, Wang LJ, Qin G. Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis. Medicine (Baltimore). 2016;95:e2506. [PMID: 26817889 DOI: 10.1097/MD.0000000000002506] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
551 Ren Y, Li S, Song Z, Luo Q, Zhang Y, Wang H. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases. Nutrients 2022;14:2303. [PMID: 35684103 DOI: 10.3390/nu14112303] [Reference Citation Analysis]
552 Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G. Sonoporation by microbubbles as gene therapy approach against liver cancer. Oncotarget 2018;9:32182-90. [PMID: 30181808 DOI: 10.18632/oncotarget.25875] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
553 Pan Q, Chen MM, Zhang RN, Wang YQ, Zheng RD, Mi YQ, Liu WB, Shen F, Su Q, Fan JG. PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism. J Diabetes Res. 2017;2017:4740124. [PMID: 28695131 DOI: 10.1155/2017/4740124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
554 Zhang X, Kuang G, Wan J, Jiang R, Ma L, Gong X, Liu X. Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation. Int Immunopharmacol 2020;85:106662. [PMID: 32544869 DOI: 10.1016/j.intimp.2020.106662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
555 French SW. How to prevent alcoholic liver disease. Exp Mol Pathol. 2015;98:304-307. [PMID: 25758202 DOI: 10.1016/j.yexmp.2015.03.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
556 Song T, Wang L, Xin R, Zhang L, Tian Y. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds. J Int Med Res 2020;48:300060520969087. [PMID: 33135527 DOI: 10.1177/0300060520969087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
557 Liu J, Wang J, Yan T, Du D, Qi C, Cao F, Yao N, Yang Y, He Y, Tian Z, Ren D, Zhu L, Chen T, Zhao Y. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice. J Viral Hepat 2019;26:1170-7. [PMID: 31177596 DOI: 10.1111/jvh.13156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
558 Russo FP, Viganò M, Stock P, Ferrarese A, Pugliese N, Burra P, Aghemo A. HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.007] [Reference Citation Analysis]
559 Huang X, Li Y, Long L. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma. Med Sci Monit 2019;25:8595-601. [PMID: 31726461 DOI: 10.12659/MSM.917418] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
560 Tan L, Yang Y, Ma G, Zhu T, Yang J, Liu H, Zhang W. Early acute kidney injury after liver transplantation in patients with normal preoperative renal function. Clin Res Hepatol Gastroenterol 2019;43:475-82. [PMID: 31126850 DOI: 10.1016/j.clinre.2018.07.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
561 Wen X, Yin S, Cui L, Mao L, Lin Z, Yaermaimaiti Z, Geng X, Li Y, Yang Y, Cui D, Mao Z. The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis. Front Public Health 2021;9:718013. [PMID: 34760861 DOI: 10.3389/fpubh.2021.718013] [Reference Citation Analysis]
562 Chen Q, Zhan Q, Li Y, Sun S, Zhao L, Zhang H, Zhang G. Schisandra Lignan Extract Protects against Carbon Tetrachloride-Induced Liver Injury in Mice by Inhibiting Oxidative Stress and Regulating the NF-κB and JNK Signaling Pathways. Evid Based Complement Alternat Med 2017;2017:5140297. [PMID: 28246539 DOI: 10.1155/2017/5140297] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
563 Teschke R, Wolff A, Eickhoff A, Danan G. Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury? JGH Open 2018;2:152-7. [PMID: 30483581 DOI: 10.1002/jgh3.12057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
564 Yang S, Chen G, Li Y, Li G, Liang Y, Zhou F, Zhou S, Yang Y, Jia W, Gao Y, Chen Y. The trend of direct medical costs and associated factors in patients with chronic hepatitis B in Guangzhou, China: an eight-year retrospective cohort study. BMC Med Inform Decis Mak 2021;21:71. [PMID: 34330262 DOI: 10.1186/s12911-021-01429-6] [Reference Citation Analysis]
565 Yao CK, Fung J, Chu NHS, Tan VPY. Dietary Interventions in Liver Cirrhosis. J Clin Gastroenterol. 2018;52:663-673. [PMID: 29912757 DOI: 10.1097/mcg.0000000000001071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
566 Liu L, Li P, Mi Y, Liu Y, Liu Y, Zhang P. Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B. Medicine (Baltimore) 2019;98:e17945. [PMID: 31725651 DOI: 10.1097/MD.0000000000017945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
567 Qiu D, Chen J, Liu J, Luo Z, Jiang W, Huang J, Qiu Z, Yue W, Wu L. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues. Exp Biol Med (Maywood) 2017;242:939-44. [PMID: 28440732 DOI: 10.1177/1535370217697382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
568 Sun XH, Wang YT, Li GF, Zhang N, Fan L. Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma. Cancer Cell Int 2020;20:226. [PMID: 32536814 DOI: 10.1186/s12935-020-01302-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
569 Mejia LM. Oral Manifestations of Gastrointestinal Disorders. Atlas Oral Maxillofac Surg Clin North Am 2017;25:93-104. [PMID: 28778312 DOI: 10.1016/j.cxom.2017.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
570 Huang C, Huang S, Tang Y, Zhao Q, Wang D, Ju W, Yang L, Zhang J, Wu L, Chen M, Zhang Z, Zhu Z, Wang L, Zhu C, Zhang Y, Sun C, Xiong W, Shen Y, Chen X, Ma Y, Hu A, Zhu X, Rong J, Cai C, Guo Z, He X. Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease. BMJ Open 2020;10:e035374. [PMID: 32376754 DOI: 10.1136/bmjopen-2019-035374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
571 Cao Z, Liu Y, Wang S, Lu X, Yin S, Jiang S, Chen L, Cai M, Zeng B, Yao Y, Tang W, Zhao G, Xiang X, Wang H, Cai W, Zhu C, Li H, Xie Q. The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infection. Liver Int. 2019;39:1943-1953. [PMID: 31206235 DOI: 10.1111/liv.14176] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
572 Liu Y, Yin J, Dawsey SM, Liu B, Freedman ND, Cui J, Taylor PR, Yin L, Abnet CC, Fan J, Chen W, Zhong L, Qiao Y. Relationships between serum iron and liver diseases in nutrition intervention trials: A nested case-control study. Cancer Epidemiol 2022;78:102157. [PMID: 35421712 DOI: 10.1016/j.canep.2022.102157] [Reference Citation Analysis]
573 Zhang KL, Chen XQ, Lv ZL, Tang Q, Shan QW. A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B. Medicine (Baltimore) 2021;100:e26462. [PMID: 34160448 DOI: 10.1097/MD.0000000000026462] [Reference Citation Analysis]
574 Xiao J, Lin H, Liu T, Zeng W, Li X, Shao X, Tan Q, Xu Y, Xu X, Zheng H, Ma W. Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China. Int J Environ Res Public Health 2015;12:14055-67. [PMID: 26540065 DOI: 10.3390/ijerph121114055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
575 Durot I, Akhbardeh A, Rosenberg J, Willmann JK. Point Shear Wave Elastography for Grading Liver Fibrosis: Can the Number of Measurements Be Reduced? Ultrasound Med Biol 2018;44:2569-77. [PMID: 30224172 DOI: 10.1016/j.ultrasmedbio.2018.07.028] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
576 Pan Q, Zhang RN, Wang YQ, Zheng RD, Mi YQ, Liu WB, Shen F, Chen GY, Lu JF, Zhu CY, Zhang SY, Chen YM, Sun WL, Fan JG. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B. World J Gastroenterol 2015; 21(28): 8605-8614 [PMID: 26229402 DOI: 10.3748/wjg.v21.i28.8605] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
577 Li X, Jiang X, Sun J, Zhu C, Bai W. Recent advances of medical foods in China: The opportunities and challenges under standardization. Food Chem Toxicol 2018;119:342-54. [PMID: 29452191 DOI: 10.1016/j.fct.2018.02.024] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
578 Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Front Med 2020;14:21-9. [PMID: 31974872 DOI: 10.1007/s11684-020-0744-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
579 Huang Z, Wu X, Li S, Li K. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma. Ultrasound Med Biol 2020;46:1403-11. [PMID: 32165015 DOI: 10.1016/j.ultrasmedbio.2020.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
580 Shan L, Jiang T, Ci L, Liu Z, Lv X, Li J. Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease. Mol Cell Biochem 2020;466:91-102. [PMID: 31989367 DOI: 10.1007/s11010-020-03691-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
581 Zhu ML, Xu XL, Wang XJ, Zhang NN, Lu KJ, Qi J, Jin FY, Liu D, Du YZ. Sialic-Acid-Anchored Micelles: A Hierarchical Targeting Device for Enhanced Tumor Tissue Accumulation and Cellular Internalization. Mol Pharm 2018;15:4235-46. [PMID: 30110551 DOI: 10.1021/acs.molpharmaceut.8b00649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
582 Liu C, Xing W, Si T, Yu H, Guo Z. Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study. Oncotarget 2017;8:100734-45. [PMID: 29246017 DOI: 10.18632/oncotarget.20140] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
583 Irvine KM, Wockner LF, Shanker M, Fagan KJ, Horsfall LU, Fletcher LM, Ungerer JP, Pretorius CJ, Miller GC, Clouston AD, Lampe G, Powell EE. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease. Liver Int 2016;36:370-7. [PMID: 26104018 DOI: 10.1111/liv.12896] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
584 Li JZ, Ye LH, Wang DH, Zhang HC, Li TY, Liu ZQ, Dai EH, Li MR. The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Res 2021;298:198405. [PMID: 33775752 DOI: 10.1016/j.virusres.2021.198405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
585 Wu G, Niu M, Tang W, Hu J, Wei G, He Z, Chen Y, Jiang Y, Chen P. L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. J Transl Med 2018;16:344. [PMID: 30526624 DOI: 10.1186/s12967-018-1718-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
586 Yang XA, Lv F, Wang R, Chang Y, Zhao Y, Cui X, Li H, Yang S, Li S, Zhao X, Mo Z, Yang F. Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B.Gut Pathog. 2020;12:50. [PMID: 33117435 DOI: 10.1186/s13099-020-00391-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
587 Zhang GL, Xu SC, Zeng J, Chen Z, Li YP, Zhang T, Gao ZL. Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Dis Markers 2019;2019:2585409. [PMID: 31885733 DOI: 10.1155/2019/2585409] [Reference Citation Analysis]
588 Méndez-Sánchez N, Zamarripa-Dorsey F, Panduro A, Purón-González E, Coronado-Alejandro EU, Cortez-Hernández CA, Higuera de la Tijera F, Pérez-Hernández JL, Cerda-Reyes E, Rodríguez-Hernández H, Cruz-Ramón VC, Ramírez-Pérez OL, Aguilar-Olivos NE, Rodríguez-Martínez OF, Cabrera-Palma S, Cabrera-Álvarez G. Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions. World J Clin Cases 2018; 6(15): 922-930 [PMID: 30568947 DOI: 10.12998/wjcc.v6.i15.922] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
589 Hou FJ, Guo LX, Zheng KY, Song JN, Wang Q, Zheng YG. Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells. Onco Targets Ther 2019;12:6685-97. [PMID: 31695406 DOI: 10.2147/OTT.S215103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
590 Fu Y, Chung FL. Oxidative stress and hepatocarcinogenesis. Hepatoma Res. 2018;4. [PMID: 30761356 DOI: 10.20517/2394-5079.2018.29] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
591 Li S, Zhou J, Xu S, Li J, Liu J, Lu Y, Shi J, Zhou S, Wu Q. Induction of Nrf2 pathway by Dendrobium nobile Lindl. alkaloids protects against carbon tetrachloride induced acute liver injury. Biomed Pharmacother 2019;117:109073. [PMID: 31212129 DOI: 10.1016/j.biopha.2019.109073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
592 Shen FF, Wang Y, Wang YF, Zheng RD, Xian JC, Shi JP, Qu Y, Dong YW, Xu MY, Lu LG. Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model. J Transl Med 2018;16:166. [PMID: 29914513 DOI: 10.1186/s12967-018-1538-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
593 Wang J, Zhao P, Wan Z, Jin X, Cheng Y, Yan T, Qing S, Ding N, Xin S. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells. Cell Biochem Funct 2016;34:475-82. [PMID: 27569862 DOI: 10.1002/cbf.3210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
594 Zhang X, Wang Y, Liu P. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease. Protein Cell 2017;8:4-13. [PMID: 27757845 DOI: 10.1007/s13238-016-0327-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
595 Ma C, Zhang L, He T, Cao H, Ren X, Ma C, Yang J, Huang R, Pan G. Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy. Stem Cell Res Ther 2021;12:555. [PMID: 34717753 DOI: 10.1186/s13287-021-02619-9] [Reference Citation Analysis]
596 Qiu R, Murata S, Cheng C, Mori A, Nie Y, Mikami S, Hasegawa S, Tadokoro T, Okamoto S, Taniguchi H. A Novel Orthotopic Liver Cancer Model for Creating a Human-like Tumor Microenvironment. Cancers (Basel) 2021;13:3997. [PMID: 34439154 DOI: 10.3390/cancers13163997] [Reference Citation Analysis]
597 Han B, Wang H, Yang W, Wang J, Wei X. Hierarchical Pt-decorated In2O3 microspheres with highly enhanced isoprene sensing properties. Ceramics International 2021;47:9477-85. [DOI: 10.1016/j.ceramint.2020.12.081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
598 Yang H, Zhang MZ, Sun HW, Chai YT, Li X, Jiang Q, Hou J. A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Front Oncol 2021;11:783194. [PMID: 34869036 DOI: 10.3389/fonc.2021.783194] [Reference Citation Analysis]
599 Jiang XY, Huang B, Huang DP, Wei CS, Zhong WC, Peng DT, Huang FR, Tong GD. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy. World J Gastroenterol 2021; 27(11): 1101-1116 [PMID: 33776376 DOI: 10.3748/wjg.v27.i11.1101] [Reference Citation Analysis]
600 Zhu Z, Yin J, Dawsey SM, Liu B, Freedman ND, Yin L, Taylor PR, Cui J, Fan J, Liu Y, Chen W, Qiao Y, Abnet CC. Association between serum ferritin, incident primary liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: A nested case-control study. J Gastroenterol Hepatol 2021. [PMID: 34106490 DOI: 10.1111/jgh.15571] [Reference Citation Analysis]
601 Luo J, You X, Chong Y, Wu Y, Gong J, Jie Y, Li X, Xi S, Zhang Z, Zhang Y, Xie D, Li Z, Li X. Efficacy of long-term treatment with tenofovir in Chinese nucleos(t)ide-naïve chronic hepatitis B patients regardless of baseline viral load. Exp Ther Med 2019;18:260-8. [PMID: 31258661 DOI: 10.3892/etm.2019.7547] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
602 Zhou M, Deng Y, Liu M, Liao L, Dai X, Guo C, Zhao X, He L, Peng C, Li Y. The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol 2021;890:173655. [PMID: 33068590 DOI: 10.1016/j.ejphar.2020.173655] [Reference Citation Analysis]
603 Xia L, Song M, Sun M, Wang F, Yang C. Circular RNAs as Biomarkers for Cancer. Adv Exp Med Biol. 2018;1087:171-187. [PMID: 30259366 DOI: 10.1007/978-981-13-1426-1_14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
604 Tang Y, Xu Y, Liu P, Liu C, Zhong R, Yu X, Xiao L, Du M, Yang L, Yuan J, Wang Y, Chen W, Wei S, Liang Y, Zhang X, Wu T, He M, Miao X, Yao P, Quiles JL. No Evidence for a Causal Link between Serum Uric Acid and Nonalcoholic Fatty Liver Disease from the Dongfeng-Tongji Cohort Study. Oxidative Medicine and Cellular Longevity 2022;2022:1-10. [DOI: 10.1155/2022/6687626] [Reference Citation Analysis]
605 Yan X, Fu X, Cai C, Zi X, Yao H, Qiu Y. Validation of models in patients with hepatocellular carcinoma: comparison of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging system in a Chinese cohort. European Journal of Gastroenterology & Hepatology 2015;27:1180-6. [DOI: 10.1097/meg.0000000000000418] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
606 Cho YD, Yoon S, Kang K, Kim Y, Lee SB, Seo D, Ryu K, Jeong J, Choi D. Simple Maturation of Direct-Converted Hepatocytes Derived from Fibroblasts. Tissue Eng Regen Med 2017;14:579-86. [PMID: 30603511 DOI: 10.1007/s13770-017-0064-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
607 Wu Y, Liu L, Zhao Y, Zhao R. Polysaccharides of vinegar-baked radix bupleuri promote the hepatic targeting effect of oxymatrine by regulating the protein expression of HNF4α, Mrp2, and OCT1. J Ethnopharmacol 2021;267:113471. [PMID: 33075440 DOI: 10.1016/j.jep.2020.113471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
608 Chen ZW, Li Z, Wang QH, Wu XL, Li H, Ren H, Hu P. Large Disparity between Prevalence and Treatment Rates for Hepatitis C in Western China. J Clin Transl Hepatol 2018;6:385-90. [PMID: 30637215 DOI: 10.14218/JCTH.2018.00027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
609 Zheng Y, Wu J, Ding C, Xu K, Yang S, Li L. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study. Virol J 2020;17:132. [PMID: 32859216 DOI: 10.1186/s12985-020-01393-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
610 Li M, Wang ZQ, Zhang L, Zheng H, Zhou MG, Liu DW. Burden of viral hepatitis caused by specific aetiologies in China, 1990-2016: findings from the GBD 2016. BMC Public Health 2020;20:1461. [PMID: 32993585 DOI: 10.1186/s12889-020-09533-4] [Reference Citation Analysis]
611 Yang A, Guo Z, Ren Q, Wu L, Ma Y, Hu A, Wang D, Ye H, Zhu X, Ju W, He X. Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study. PLoS One 2017;12:e0188190. [PMID: 29145470 DOI: 10.1371/journal.pone.0188190] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
612 Guo J, Shirozu K, Akahoshi T, Mizuta Y, Murata M, Yamaura K. The farnesyltransferase inhibitor tipifarnib protects against autoimmune hepatitis induced by Concanavalin A. Int Immunopharmacol 2020;83:106462. [PMID: 32251961 DOI: 10.1016/j.intimp.2020.106462] [Reference Citation Analysis]
613 Yan W, Zhu Z, Pan F, Huang A, Dai GH. Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma. Onco Targets Ther 2018;11:1285-92. [PMID: 29563807 DOI: 10.2147/OTT.S157545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
614 Wang H, Gao Q, He S, Bao Y, Sun H, Meng L, Liang J, Sun C, Chen S, Cao L, Huang W, Zhang Y, Huang J, Wu S, Wang T. Self-reported snoring is associated with nonalcoholic fatty liver disease. Sci Rep 2020;10:9267. [PMID: 32518245 DOI: 10.1038/s41598-020-66208-1] [Reference Citation Analysis]
615 Zhang N, Tao D, Lei H, Shao Q, Liu Y, Long H, Zeng X. HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease. JIR 2022;Volume 15:2509-21. [DOI: 10.2147/jir.s355301] [Reference Citation Analysis]
616 Wang Y, Wu T, Hu D, Weng X, Wang X, Chen PJ, Luo X, Wang H, Ning Q. Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein. J Lipid Res 2018;59:58-68. [PMID: 29133292 DOI: 10.1194/jlr.M079533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
617 Li T, Wang R, Zhao Y, Su S, Zeng H. Public awareness and influencing factors regarding hepatitis B and hepatitis C in Chongqing municipality and Chengdu City, China: a cross-sectional study with community residents. BMJ Open 2021;11:e045630. [PMID: 34341038 DOI: 10.1136/bmjopen-2020-045630] [Reference Citation Analysis]
618 Zhou HY, Liu S, Zheng SJ, Peng XX, Chen Y, Duan C, Zheng QF, Wang Z, Duan ZP. Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces. Hepatol Med Policy 2016;1:7. [PMID: 30288311 DOI: 10.1186/s41124-016-0008-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
619 Zhu Z, Huang J, Liao M, Zeng Y. Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection. Jpn J Clin Oncol . [DOI: 10.1093/jjco/hyw134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
620 Cong M, Ou X, Huang J, Long J, Li T, Liu X, Wang Y, Wu X, Zhou J, Sun Y, Shang Q, Chen G, Ma H, Xie W, Piao H, Yang Y, Gao Z, Xu X, Tan Z, Chen C, Zeng N, Wu S, Kong Y, Liu T, Wang P, You H, Jia J, Zhuang H. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus. OMICS 2020;24:415-23. [PMID: 32522092 DOI: 10.1089/omi.2020.0055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
621 Valery PC, Clark PJ, McPhail SM, Rahman T, Hayward K, Martin J, Horsfall L, Volk ML, Skoien R, Powell E. Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. Intern Med J 2017;47:429-35. [PMID: 28145084 DOI: 10.1111/imj.13380] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
622 Wang Y, Ji C, Wang Y, Ji M, Yang J, Zhou C. Predicting postoperative liver cancer death outcomes with machine learning. Current Medical Research and Opinion 2021;37:629-34. [DOI: 10.1080/03007995.2021.1885361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Li X, Dong G, Xiong H, Diao H. A narrative review of the role of necroptosis in liver disease: a double-edged sword. Ann Transl Med 2021;9:422. [PMID: 33842643 DOI: 10.21037/atm-20-5162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
624 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
625 Lee HF, Chan YH, Chang SH, Tu HT, Chen SW, Yeh YH, Wu LS, Kuo CF, Kuo CT, See LC. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation. J Am Heart Assoc 2019;8:e011112. [PMID: 30834802 DOI: 10.1161/JAHA.118.011112] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
626 Im PK, Millwood IY, Kartsonaki C, Chen Y, Guo Y, Du H, Bian Z, Lan J, Feng S, Yu C, Lv J, Walters RG, Li L, Yang L, Chen Z; China Kadoorie Biobank (CKB) Collaborative Group. Alcohol drinking and risks of total and site-specific cancers in China: A 10-year prospective study of 0.5 million adults. Int J Cancer 2021;149:522-34. [PMID: 33634874 DOI: 10.1002/ijc.33538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
627 Mf Akbar S, Al-Mahtab M, I Khan S. Nature of Host Immunity during Hepatitis B Virus Infection and designing Immune Therapy. Euroasian J Hepatogastroenterol 2018;8:42-6. [PMID: 29963460 DOI: 10.5005/jp-journals-10018-1256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
628 Wang K, Yang X, Wu Z, Wang H, Li Q, Mei H, You R, Zhang Y. Dendrobium officinale Polysaccharide Protected CCl4-Induced Liver Fibrosis Through Intestinal Homeostasis and the LPS-TLR4-NF-κB Signaling Pathway. Front Pharmacol 2020;11:240. [PMID: 32226380 DOI: 10.3389/fphar.2020.00240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
629 Shen J, Zhu X, Wu Z, Shi Y, Wen T. Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells. Phytomedicine 2021;94:153793. [PMID: 34736000 DOI: 10.1016/j.phymed.2021.153793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
630 Nwidu LL, Elmorsy E, Oboma YI, Carter WG. Hepatoprotective and antioxidant activities of Spondias mombin leaf and stem extracts against carbon tetrachloride-induced hepatotoxicity. J Taibah Univ Med Sci 2018;13:262-71. [PMID: 31435333 DOI: 10.1016/j.jtumed.2018.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
631 Zhang Y, Li D, Feng F, An L, Hui F, Dang D, Zhao Q. Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Sci Rep 2017;7:14809. [PMID: 29093570 DOI: 10.1038/s41598-017-14897-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
632 Jiang W, Wang J, Xue W, Xin J, Shi C, Wen J, Feng X, Huang Y, Hu C. Caveolin-1 attenuates acetaminophen aggravated lipid accumulation in alcoholic fatty liver by activating mitophagy via the Pink-1/Parkin pathway. Eur J Pharmacol 2021;908:174324. [PMID: 34246650 DOI: 10.1016/j.ejphar.2021.174324] [Reference Citation Analysis]
633 Yang T, Zhang H, Lau WY, Shen F, Wu MC. Liver disease in China: A long way to go. Hepatology 2015;62:1640. [PMID: 25722082 DOI: 10.1002/hep.27769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
634 Li Y, Huang W, Li C, Huang X. Indocyanine green conjugated lipid microbubbles as an ultrasound-responsive drug delivery system for dual-imaging guided tumor-targeted therapy. RSC Adv 2018;8:33198-207. [DOI: 10.1039/c8ra03193b] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
635 Zhao T, Jia L, Li J, Ma C, Wu J, Shen J, Dang L, Zhu B, Li P, Zhi Y, Lan R, Xu Y, Hao Z, Chai Y, Li Q, Hu L, Sun S. Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations. Front Oncol 2020;10:496. [PMID: 32426269 DOI: 10.3389/fonc.2020.00496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
636 Zhang E, Yin S, Zhao S, Zhao C, Yan M, Fan L, Hu H. Protective effects of glycycoumarin on liver diseases. Phytother Res 2020;34:1191-7. [PMID: 31840883 DOI: 10.1002/ptr.6598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
637 Li YM, Fan JG; National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Disease Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for alcoholic liver disease (2018, China). J Dig Dis 2019;20:174-80. [PMID: 30450822 DOI: 10.1111/1751-2980.12687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
638 Wu Y, Min J, Ge C, Shu J, Tian D, Yuan Y, Zhou D. Interleukin 22 in Liver Injury, Inflammation and Cancer. Int J Biol Sci 2020;16:2405-13. [PMID: 32760208 DOI: 10.7150/ijbs.38925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
639 Liu J, Ren W, Ai H, Dun G, Ji Y, Zhang Y, Wan Q, Lin S. Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B. Ultrasound Med Biol 2018;44:1177-86. [PMID: 29609809 DOI: 10.1016/j.ultrasmedbio.2018.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
640 Wang ZH, Zheng KI, Wang XD, Qiao J, Li YY, Zhang L, Zheng MH, Wu J. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00115-6. [PMID: 34256994 DOI: 10.1016/j.hbpd.2021.05.008] [Reference Citation Analysis]
641 Sun YH, Zhang XY, Xie WQ, Liu GJ, He XX, Huang YL, Zhang GX, Wang J, Kuang ZY, Zhang R. Identification of UQCRB as an oxymatrine recognizing protein using a T7 phage display screen. J Ethnopharmacol 2016;193:133-9. [PMID: 27497639 DOI: 10.1016/j.jep.2016.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
642 Wu J, Mao W. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases. Dis Markers 2020;2020:2471252. [PMID: 32774512 DOI: 10.1155/2020/2471252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Liao Y. Obstacles and opportunities in the prevention and treatment of HBV-related hepatocellular carcinoma. Genes Dis 2020;7:291-8. [PMID: 32884983 DOI: 10.1016/j.gendis.2019.12.014] [Reference Citation Analysis]
644 Yoon S, Kang K, Cho YD, Kim Y, Buisson EM, Yim JH, Lee SB, Ryu KY, Jeong J, Choi D. Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells. Biomed Res Int 2018;2018:8240567. [PMID: 30327781 DOI: 10.1155/2018/8240567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
645 Ullah W, Abdullah HMA, Ahmad E, Rashid MU, Bashir M, Ur Rahman A, Ahmad A, Hurairah A. A Bibliometric Analysis of the Top 100 Cited Articles on Hepatic Magnetic Resonance Imaging. Cureus 2018;10:e2733. [PMID: 30087809 DOI: 10.7759/cureus.2733] [Reference Citation Analysis]
646 Chen XZ, Zhang WK, Tang HB, Li XJ, Tian GH, Shang HC, Li YS. The Ethanol Supernatant Extracts of Liushenwan Could Alleviate Nanodiethylnitrosamine-Induced Liver Cancer in Mice. Can J Gastroenterol Hepatol 2018;2018:6934809. [PMID: 30356380 DOI: 10.1155/2018/6934809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
647 Negm O, Abou Saif S, El Gharib M, Yousef M, Abd-Elsalam S. Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2017;29:317-21. [PMID: 27893491 DOI: 10.1097/MEG.0000000000000790] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
648 Li T, Su S, Zhao Y, Deng R, Fan M, Wang R, Sharma M, Zeng H. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. Int J Environ Res Public Health 2019;16:E231. [PMID: 30650581 DOI: 10.3390/ijerph16020231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
649 Han L, Zhang Y, Yue C, Huang Y, Wu Y, Chen J, Khan R. Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population. Journal of Healthcare Engineering 2022;2022:1-10. [DOI: 10.1155/2022/9331284] [Reference Citation Analysis]
650 Rezvani Habibabadi R, Huntley JH, Jalilianhasanpour R, Yousem DM. Which vendor is most cited in the hepatic imaging literature? Clin Imaging 2021;71:39-43. [PMID: 33171365 DOI: 10.1016/j.clinimag.2020.10.018] [Reference Citation Analysis]
651 Witzigmann D, Kulkarni JA, Leung J, Chen S, Cullis PR, van der Meel R. Lipid nanoparticle technology for therapeutic gene regulation in the liver. Adv Drug Deliv Rev 2020;159:344-63. [PMID: 32622021 DOI: 10.1016/j.addr.2020.06.026] [Cited by in Crossref: 69] [Cited by in F6Publishing: 54] [Article Influence: 34.5] [Reference Citation Analysis]
652 Zhang L, Zou X, Xu Y, Medland N, Deng L, Liu Y, Su S, Ling L. The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden. Front Public Health 2019;7:327. [PMID: 31781529 DOI: 10.3389/fpubh.2019.00327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
653 Li M, Chen L, Liu LM, Li YL, Li BA, Li B, Mao YL, Xia LF, Wang T, Liu YN, Li Z, Guo TS. Performance verification and comparison of TianLong automatic hypersensitive hepatitis B virus DNA quantification system with Roche CAP/CTM system. World J Gastroenterol 2017; 23(37): 6845-6853 [PMID: 29085227 DOI: 10.3748/wjg.v23.i37.6845] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
654 Hu J, Li P, Song Y, Ge YX, Meng XM, Huang C, Li J, Xu T. Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function. J Cell Physiol. 2018;233:4408-4422. [PMID: 28833094 DOI: 10.1002/jcp.26154] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
655 Zhang X, Wang Y, Li X, Yang A, Li Z, Wang D. The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer. Aging (Albany NY) 2019;11:10284-300. [PMID: 31754081 DOI: 10.18632/aging.102456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
656 Xiao LL, Xu XW, Huang KZ, Zhao YL, Zhang LJ, Li LJ. Artificial Liver Support System Improves Short-Term Outcomes of Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Propensity Score Analysis. Biomed Res Int 2019;2019:3757149. [PMID: 31871940 DOI: 10.1155/2019/3757149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
657 El-mezayen NS, El-hadidy WF, El-refaie WM, Shalaby T, Khattab MM, El-khatib AS. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis. Journal of Controlled Release 2017;266:226-37. [DOI: 10.1016/j.jconrel.2017.09.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
658 Cheng Y, Xie Y, Ge J, Wang L, Peng D, Yu N, Zhang Y, Jiang Y, Luo J, Chen W. Structural characterization and hepatoprotective activity of a galactoglucan from Poria cocos. Carbohydrate Polymers 2021;263:117979. [DOI: 10.1016/j.carbpol.2021.117979] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
659 Yang RX, Hu CX, Sun WL, Pan Q, Shen F, Yang Z, Su Q, Xu GW, Fan JG. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B. Sci Rep. 2017;7:10517. [PMID: 28874844 DOI: 10.1038/s41598-017-11278-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
660 Lu T, Hao J, Shen C, Gu G, Zhang J, Xu N. Partial Hepatectomy-Induced Upregulation of miR-1907 Accelerates Liver Regeneration by Activation Autophagy. Biomed Res Int 2018;2018:3817057. [PMID: 30151380 DOI: 10.1155/2018/3817057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
661 Roesch-Dietlen F, González-Santes M, Sánchez-Maza YJ, Díaz-Roesch F, Cano-Contreras AD, Amieva-Balmori M, García-Zermeño KR, Salgado-Vergara L, Remes-Troche JM, Ortigoza-Gutiérrez S. Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liver. Rev Gastroenterol Mex (Engl Ed) 2021;86:28-35. [PMID: 32345507 DOI: 10.1016/j.rgmx.2020.01.002] [Reference Citation Analysis]
662 Huang R, Duan X, Liu X, Cao H, Wang Y, Fan J, Wang B. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. Biochem Biophys Res Commun 2019;508:1252-8. [PMID: 30558790 DOI: 10.1016/j.bbrc.2018.12.061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
663 Zhu Q, Ma Y, Liang J, Wei Z, Li M, Zhang Y, Liu M, He H, Qu C, Cai J, Wang X, Zeng Y, Jiao Y. AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma. Signal Transduct Target Ther 2021;6:299. [PMID: 34373448 DOI: 10.1038/s41392-021-00713-1] [Reference Citation Analysis]
664 Liangpunsakul S, Haber P, McCaughan GW. Alcoholic Liver Disease in Asia, Europe, and North America. Gastroenterology. 2016;150:1786-1797. [PMID: 26924091 DOI: 10.1053/j.gastro.2016.02.043] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 12.3] [Reference Citation Analysis]
665 Zhang GL, Zhao QY, Lin CS, Hu ZX, Zhang T, Gao ZL. Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:3951574. [PMID: 30809540 DOI: 10.1155/2019/3951574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
666 Chen C, Zhang X, Deng Y, Cui Q, Zhu J, Ren H, Liu Y, Hu X, Zuo J, Peng Y. Regulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid-related diseases. FEBS J 2021;288:3663-82. [PMID: 32798313 DOI: 10.1111/febs.15525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
667 Park CS, De T, Xu Y, Zhong Y, Smithberger E, Alarcon C, Gamazon ER, Perera MA. Hepatocyte gene expression and DNA methylation as ancestry-dependent mechanisms in African Americans. NPJ Genom Med 2019;4:29. [PMID: 31798965 DOI: 10.1038/s41525-019-0102-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
668 Wang Y, Tang Z. A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells. Onco Targets Ther 2018;11:8529-41. [PMID: 30555243 DOI: 10.2147/OTT.S188209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
669 Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study. Lancet Infect Dis. 2016;16:80-86. [PMID: 26268687 DOI: 10.1016/s1473-3099(15)00218-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 50] [Article Influence: 13.1] [Reference Citation Analysis]
670 Wang X, Liu J, Song T, Huang Z, Fan Y, Shi Y, Chen L, Lv Y, Xu Z, Li X, Wang L, Lin T. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)–Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China. Clinical Infectious Diseases 2021;72:1016-23. [DOI: 10.1093/cid/ciaa178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
671 He C, Zhang X, Li C, Peng W, Wen TF, Yan LN, Yang J, Lu W. Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization. Oncotarget 2017;8:85599-611. [PMID: 29156744 DOI: 10.18632/oncotarget.20343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
672 Han JJ, Chen Y, Nan YC, Yang YL. Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report. World J Clin Cases 2021; 9(28): 8492-8497 [PMID: 34754858 DOI: 10.12998/wjcc.v9.i28.8492] [Reference Citation Analysis]
673 Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci. 2017;18:E803. [PMID: 28398242 DOI: 10.3390/ijms18040803] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
674 Xu C, Chen J, Zhang PA. Relationship Between Diabetes Mellitus and Cirrhosis Risk in Chronic Hepatitis B Patients in Wuhan, China. Med Sci Monit. 2019;25:8112-8119. [PMID: 31661471 DOI: 10.12659/msm.917000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
675 Ye X, He L, Ma J, Li Y, Zhang M, Yang J, Zhang J, Xiao F, Wei H. Downregulation of Glt25d1 aggravates carbon tetrachloride‑induced acute hepatic injury through activation of the TGF‑β1/Smad2 signaling pathway. Mol Med Rep 2018;18:3611-8. [PMID: 30132521 DOI: 10.3892/mmr.2018.9392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]